1
|
Hoyos JA, Londoño DR, Hoyos AG, Reyes EC, Varela R, Giraldo JS. Impact of presentation timing in metastatic hormone-sensitive prostate cancer: Characterization of patients and identification of prognostic factors. Prostate 2024; 84:560-569. [PMID: 38311854 DOI: 10.1002/pros.24672] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/24/2023] [Revised: 12/12/2023] [Accepted: 01/19/2024] [Indexed: 02/06/2024]
Abstract
BACKGROUND The treatment and surveillance of metastatic hormone-sensitive prostate cancer (mHSPC) has evolved since the introduction of several treatment intensification options associated with hormonal blockade and classifications based on the timing of metastatic disease presentation and disease volume. Using a hospital-based registry, we aimed to assess whether these new classifications are applicable to our population, as few studies have demonstrated their prognostic value for overall survival (OS) and time to development of castration-resistant prostate cancer (CRPC), and to establish prognostic factors in our population. METHODS A retrospective cohort of mHSPC patients who were attended at an oncology referral hospital in Bogota between 2017 and 2021 were included in this study. The primary and secondary endpoints were OS and time to CRPC. The distribution of outcome measures was estimated using the Kaplan-Meier method. Proportional hazard models were constructed using the Cox regression approach and stratified according to risk factors. RESULTS The study cohort included 373 patients. The median castration resistance-free survival was 48 months (CI: 32-73 months), and OS was 43 months (CI: 37-48 months). In multivariate analysis, nodal staging, ECOG status, and surgical castration were independent prognostic factors. CONCLUSION In our hospital-based registry, the independent impact of the time of presentation on castration-resistant-free survival or OS could not be demonstrated, nor could the grouping of prognostic categories based on metastatic presentation temporality and volume. Other independent prognostic factors have been proposed.
Collapse
Affiliation(s)
- Juliana Arenas Hoyos
- Division of Urology, Pontificia Universidad Javeriana, Hospital Universitario San Igancio, Bogota, Colombia
| | - David Ruiz Londoño
- Division of Uro-Oncology, Colombian National Cancer Institute, Bogotá, Colombia
| | - Andres Gomez Hoyos
- Division of Uro-Oncology, Colombian National Cancer Institute, Bogotá, Colombia
| | | | - Rodolfo Varela
- Division of Uro-Oncology, Colombian National Cancer Institute, Bogotá, Colombia
| | - Julian Serrano Giraldo
- Division of Urology, Pontificia Universidad Javeriana, Hospital Universitario San Igancio, Bogota, Colombia
| |
Collapse
|
2
|
Acosta-Vega NL, Varela R, Mesa JA, Garai J, Gómez-Gutiérrez A, Serrano-Gómez SJ, Zabaleta J, Sanabria-Salas MC, Combita AL. Genetic ancestry and radical prostatectomy findings in Hispanic/Latino patients. Front Oncol 2024; 14:1338250. [PMID: 38634046 PMCID: PMC11021589 DOI: 10.3389/fonc.2024.1338250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2023] [Accepted: 03/18/2024] [Indexed: 04/19/2024] Open
Abstract
Background African ancestry is a known factor associated with the presentation and aggressiveness of prostate cancer (PC). Hispanic/Latino populations exhibit varying degrees of genetic admixture across Latin American countries, leading to diverse levels of African ancestry. However, it remains unclear whether genetic ancestry plays a role in the aggressiveness of PC in Hispanic/Latino patients. We explored the associations between genetic ancestry and the clinicopathological data in Hispanic/Latino PC patients from Colombia. Patients and methods We estimated the European, Indigenous and African genetic ancestry, of 230 Colombian patients with localized/regionally advanced PC through a validated panel for genotypification of 106 Ancestry Informative Markers. We examined the associations of the genetic ancestry components with the Gleason Grade Groups (GG) and the clinicopathological characteristics. Results No association was observed between the genetic ancestry with the biochemical recurrence or Gleason GG; however, in a two groups comparison, there were statistically significant differences between GG3 and GG4/GG5 for European ancestry, with a higher mean ancestry proportion in GG4/GG5. A lower risk of being diagnosed at an advanced age was observed for patients with high African ancestry than those with low African ancestry patients (OR: 0.96, CI: 0.92-0.99, p=0.03). Conclusion Our findings revealed an increased risk of presentation of PC at an earlier age in patients with higher African ancestry compared to patients with lower African ancestry in our Hispanic/Latino patients.
Collapse
Affiliation(s)
- Natalia L. Acosta-Vega
- Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá D.C., Colombia
- Programa de doctorado en Ciencias Biológicas, Pontificia Universidad Javeriana, Bogotá D.C., Colombia
| | - Rodolfo Varela
- Departamento de Urología, Instituto Nacional de Cancerología de Colombia, Bogotá D.C., Colombia
- Departamento de Cirugía, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia
| | - Jorge Andrés Mesa
- Departamento de Patología Oncológica, Instituto Nacional de Cancerología de Colombia, Bogotá D.C., Colombia
| | - Jone Garai
- Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States
| | - Alberto Gómez-Gutiérrez
- Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá D.C., Colombia
| | - Silvia J. Serrano-Gómez
- Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá D.C., Colombia
| | - Jovanny Zabaleta
- Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States
- Department of Interdisciplinary Oncology, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, United States
| | - María Carolina Sanabria-Salas
- Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá D.C., Colombia
| | - Alba L. Combita
- Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá D.C., Colombia
- Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia
| |
Collapse
|
3
|
Varela R, de Castro M, Dias JM, Gómez-Gesteira M. Coastal warming under climate change: Global, faster and heterogeneous. Sci Total Environ 2023; 886:164029. [PMID: 37169187 DOI: 10.1016/j.scitotenv.2023.164029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/03/2023] [Revised: 05/04/2023] [Accepted: 05/05/2023] [Indexed: 05/13/2023]
Abstract
The assessment of expected changes in coastal sea surface temperature (SST) on a global scale is becoming increasingly important due to the growing pressure on coastal ecosystems caused by climate change. To achieve this objective, 17 Global Climate Models from CMIP6 were used, with data from historical and hist-1950 experiments spanning 1982-2050. This analysis highlights significant warming of coastal areas worldwide, with higher and more variable rates of warming than observed in previous decades. All basins are projected to experience an increase in coastal SST near 1 °C by mid-century, with some regions exhibiting nearshore SST anomalies exceeding 2 °C for the period 2031-2050 relative to 1995-2014. Regarding the Eastern Upwelling Boundary Systems, only the Canary upwelling system and the southern part of the Humboldt upwelling system manage to show lower-than-average SST warming rates, maintaining, to a certain extent, their ability to buffer global warming.
Collapse
Affiliation(s)
- R Varela
- EphysLab - Environmental Physics Laboratory, CIM-UVIGO, Universidade de Vigo, Edificio Campus da Auga, 32004 Ourense, Spain; CESAM - Centre for Environmental and Marine Studies, Department of Physics, University of Aveiro, 3810-193 Aveiro, Portugal.
| | - M de Castro
- EphysLab - Environmental Physics Laboratory, CIM-UVIGO, Universidade de Vigo, Edificio Campus da Auga, 32004 Ourense, Spain; CESAM - Centre for Environmental and Marine Studies, Department of Physics, University of Aveiro, 3810-193 Aveiro, Portugal
| | - J M Dias
- CESAM - Centre for Environmental and Marine Studies, Department of Physics, University of Aveiro, 3810-193 Aveiro, Portugal
| | - M Gómez-Gesteira
- EphysLab - Environmental Physics Laboratory, CIM-UVIGO, Universidade de Vigo, Edificio Campus da Auga, 32004 Ourense, Spain; CESAM - Centre for Environmental and Marine Studies, Department of Physics, University of Aveiro, 3810-193 Aveiro, Portugal
| |
Collapse
|
4
|
Brassetti A, Anceschi U, Cozzi G, Chavarriaga J, Gavrilov P, Gaya Sopena JM, Bove AM, Prata F, Ferriero M, Mastroianni R, Misuraca L, Tuderti G, Torregiani G, Covotta M, Camacho D, Musi G, Varela R, Breda A, De Cobelli O, Simone G. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The Tetrafecta Achievement. Curr Oncol 2023; 30:1882-1892. [PMID: 36826107 PMCID: PMC9954864 DOI: 10.3390/curroncol30020146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2022] [Revised: 01/23/2023] [Accepted: 01/30/2023] [Indexed: 02/09/2023] Open
Abstract
BACKGROUND To optimize results reporting after penile cancer (PC) surgery, we proposed a Tetrafecta and assessed its ability to predict overall survival (OS) probabilities. METHODS A purpose-built multicenter, multi-national database was queried for stage I-IIIB PC, requiring inguinal lymphadenectomy (ILND), from 2015 onwards. Kaplan-Meier (KM) method assessed differences in OS between patients achieving Tetrafecta or not. Univariable and multivariable regression analyses identified its predictors. RESULTS A total of 154 patients were included in the analysis. The 45 patients (29%) that achieved the Tetrafecta were younger (59 vs. 62 years; p = 0.01) and presented with fewer comorbidities (ASA score ≥ 3: 0% vs. 24%; p < 0.001). Although indicated, ILND was omitted in 8 cases (5%), while in 16, a modified template was properly used. Although median LNs yield was 17 (IQR: 11-27), 35% of the patients had <7 nodes retrieved from the groin. At Kaplan-Maier analysis, the Tetrafecta cohort displayed significantly higher OS probabilities (Log Rank = 0.01). Uni- and multivariable logistic regression analyses identified age as the only independent predictor of Tetrafecta achievement (OR: 0.97; 95%CI: 0.94-0.99; p = 0.04). CONCLUSIONS Our Tetrafecta is the first combined outcome to comprehensively report results after PC surgery. It is widely applicable, based on standardized and reproducible variables and it predicts all-cause mortality.
Collapse
Affiliation(s)
- Aldo Brassetti
- Department of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, Italy
- Correspondence: ; Tel.: +39-0652666772
| | - Umberto Anceschi
- Department of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, Italy
| | - Gabriele Cozzi
- Department of Urology, European Institute of Oncology, 20141 Milan, Italy
| | - Julian Chavarriaga
- Division of Urology, Clinica Imbanaco, Quiron Salud, Cali 760042, Colombia
- Division of Urology, Pontificia Universidad Javeriana, Bogota 110231, Colombia
| | - Pavel Gavrilov
- Department of Urology, Fondacio Puigvert, 08025 Barcelona, Spain
| | | | - Alfredo Maria Bove
- Department of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, Italy
| | - Francesco Prata
- Department of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, Italy
| | | | - Riccardo Mastroianni
- Department of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, Italy
| | - Leonardo Misuraca
- Department of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, Italy
| | - Gabriele Tuderti
- Department of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, Italy
| | - Giulia Torregiani
- Department of Anesthesiology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, Italy
| | - Marco Covotta
- Department of Anesthesiology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, Italy
| | - Diego Camacho
- Division of Urologic Oncology Instituto Nacional de Cancerologia, Bogota 111511, Colombia
| | - Gennaro Musi
- Department of Urology, European Institute of Oncology, 20141 Milan, Italy
| | - Rodolfo Varela
- Division of Urologic Oncology Instituto Nacional de Cancerologia, Bogota 111511, Colombia
| | - Alberto Breda
- Department of Urology, Fondacio Puigvert, 08025 Barcelona, Spain
| | - Ottavio De Cobelli
- Department of Urology, European Institute of Oncology, 20141 Milan, Italy
| | - Giuseppe Simone
- Department of Urology, IRCCS “Regina Elena” National Cancer Institute, 00144 Rome, Italy
| |
Collapse
|
5
|
Acosta-Vega NL, Varela R, Mesa JA, Garai J, Baddoo MC, Gómez-Gutiérrez A, Serrano-Gómez SJ, Lemus MN, Serrano ML, Zabaleta J, Combita AL, Sanabria-Salas MC. Metabolic pathways enriched according to ERG status are associated with biochemical recurrence in Hispanic/Latino patients with prostate cancer. Cancer Med 2023; 12:4306-4320. [PMID: 36329628 PMCID: PMC9972164 DOI: 10.1002/cam4.5301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2022] [Revised: 08/28/2022] [Accepted: 09/15/2022] [Indexed: 11/06/2022] Open
Abstract
BACKGROUND The role of ERG-status molecular subtyping in prognosis of prostate cancer (PCa) is still under debate. In this study, we identified differentially expressed genes (DEGs) according to ERG-status to explore their enriched pathways and implications in prognosis in Hispanic/Latino PCa patients. METHODS RNA from 78 Hispanic PCa tissues from radical prostatectomies (RP) were used for RNA-sequencing. ERGhigh /ERGlow tumor groups were determined based on the 1.5-fold change median expression in non-tumor samples. DEGs with a False Discovery Rate (FDR) < 0.01 and a fold change >2 were identified between ERGhigh and ERGlow tumors and submitted to enrichment analysis in MetaCore. Survival and association analyses were performed to evaluate biochemical recurrence (BCR)-free survival. RESULTS The identification of 150 DEGs between ERGhigh and ERGlow tumors revealed clustering of most of the non-BCR cases (60%) into de ERGhigh group and most of the BCR cases (60.8%) in ERGlow group. Kaplan-Meier survival curves showed a worst BCR-free survival for ERGlow patients, and a significant reduced risk of BCR was observed for ERGhigh cases (OR = 0.29 (95%CI, 0.10-0.8)). Enrichment pathway analysis identified metabolic-related pathways, such as the renin-angiotensin system and angiotensin maturation system, the linoleic acid metabolism, and polyamines metabolism in these ERG groups. CONCLUSIONS ERGlow tumor cases were associated with poor BCR-free survival in our Hispanic/Latino patients, with metabolism-related pathways altered in the BCR progression. IMPACT Our findings suggest the need to dissect the role of diet, metabolism, and lifestyle as risk factors for more aggressive PCa subtypes.
Collapse
Affiliation(s)
- Natalia L Acosta-Vega
- Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia.,Programa de doctorado en Ciencias Biológicas, Pontificia Universidad Javeriana, Bogotá, DC, Colombia
| | - Rodolfo Varela
- Departamento de Urología, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia
| | - Jorge Andrés Mesa
- Departamento de Patología Oncológica, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia
| | - Jone Garai
- Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA
| | - Melody C Baddoo
- Tulane University School of Medicine, New Orleans, Louisiana, USA
| | - Alberto Gómez-Gutiérrez
- Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, DC, Colombia
| | - Silvia J Serrano-Gómez
- Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia
| | - Marcela Nuñez Lemus
- Grupo de Apoyo y Seguimiento para la Investigación, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia
| | - Martha Lucía Serrano
- Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia.,Departamento de Química, Facultad de Ciencias, Universidad Nacional de Colombia, Bogotá, DC, Colombia
| | - Jovanny Zabaleta
- Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.,Department of Interdisciplinary Oncology, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA
| | - Alba L Combita
- Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia.,Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, DC, Colombia
| | | |
Collapse
|
6
|
Muacevic A, Adler JR, Gomez A, Varela R. A Retrospective Study of Metastatic Renal Cell Carcinoma Patients With Brain Metastases. Cureus 2023; 15:e34014. [PMID: 36811042 PMCID: PMC9939236 DOI: 10.7759/cureus.34014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/19/2023] [Indexed: 01/21/2023] Open
Abstract
Metastatic renal cell carcinoma (mRCC) involving the central nervous system is currently an excluded subgroup of patients in the systemic treatment; for this reason, there is no solid data to support the efficacy of therapies in this subgroup. That is why it is important to describe real-life experiences in order to know if there is a special change in clinical behavior or treatment response in these kinds of patients. Patients and methods A retrospective review was performed to characterize mRCC patients diagnosed with brain metastases (BrM) during treatment at the National Institute of Cancerology of Bogota, Colombia. Descriptive statistics and time-to-event methods are used to evaluate the cohort. For the descriptive measures of quantitative variables, the mean with standard deviation was taken, and the minimum and maximum values were reported. In the case of qualitative variables, absolute and relative frequencies were used. The software used was R - Project v4.1.2 (R Foundation for Statistical Computing, Vienna, Austria). Results A total of 16 patients were included with mRCC between January 2017 to August 2022 with a median 35.1-month follow-up, 4/16 (25%) were diagnosed with BrM at the time of screening and 12/16 (75%) during treatment. The International Metastatic RCC Database Consortium risk (IMDC) was favorable for 12.5%, intermediate for 43.7%, and poor for 25%, and not classified for 18.8%, BrM involvement was multifocal in 50% of the population and localized, brain-directed therapy was done in 43.7% of patients, predominantly palliative radiotherapy. Median overall survival (OS) for all the patients regardless of the time of metastatic presentation of the disease in the central nervous system was 53.5 months (0-70.3), and OS for cases with central nervous system involvement was 10.9 months. IMDC risk did not correlate with survival (log-rank, p=0.67). The OS for the subgroup of patients who debut with metastatic disease in the central nervous system is different from the group that developed metastasis in the progression of their disease (OS of 42 vs 3.6 months, respectively). Conclusions This is the largest descriptive study in Latin America and the second in the world from one institution that admits patients with metastasic renal cell carcinoma and central nervous system metastasis. In these kinds of patients with metastatic disease or progression to the central nervous system, there is a hypothesis that shows more aggressive clinical behavior. There is limited data on locoregional intervention to metastatic disease in the nervous system drastically, but trends show this could impact overall survival outcomes.
Collapse
|
7
|
Dominguez-Bellini C, Ramos JG, Becerra LM, Varela R. Biochemical Relapse in Low-risk Prostate Cancer Treated with Radical Prostatectomy and Bilateral Pelvic Lymphadenectomy. Revista Urología Colombiana / Colombian Urology Journal 2022. [DOI: 10.1055/s-0042-1748182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022] Open
Abstract
Abstract
Introduction For low-risk prostate cancer (PCa), curative treatment with radical prostatectomy (RP) can be performed, reporting a biochemical relapse-free survival rate (bRFS) at 5 and 7 years of 90.1% and 88.3%, respectively. Prostatic specific antigen (PSA), pathological stage (pT), and positive margins (R1) are significant predictors of biochemical relapse (BR). Even though pelvic lymphadenectomy is not recommended during RP, in the literature, it is performed in 34% of these patients, finding 0.37% of positive lymph nodes (N1). In this study, we aim to evaluate the 10-year bRFS in patients with low-risk PCa who underwent RP and extended pelvic lymph node dissection (ePLND).
Methodology All low-risk patients who underwent RP plus bilateral ePLND at the National Cancer Institute of Colombia between 2006 and 2019 were reviewed. Biochemical relapse was defined as 2 consecutive increasing levels of PSA > 0.2 ng/mL. A descriptive analysis was performed using the STATA 15 software (Stata Corp., College Station, TX, USA), and the Kaplan-Meier curves and uni and multivariate Cox proportional hazard models were used for the survival outcome analysis. The related regression coefficients were used for the hazard ratio (HR), and, for all comparisons, a two-sided p-value ˂ 0.05 was used to define statistical significance.
Results Two hundred and two patients met the study criteria. The 10-year bRFS for the general population was 82.5%, statistically related to stage pT3 (p = 0.047), higher Gleason grade group (GG) (p ≤ 0.001), and R1 (p ≤ 0.001), but not with N1. A total of 3.9% of the patients had N1; of these, 75% had R1, 25% GG2, and 37% GG3. Among the N0 (non-lymph node metástasis in prostate cáncer) patients, 31% of the patients had R1, 41% GG2, and 13% GG3.
Conclusions Our bRFS was 82.5% in low-risk patients who underwent RP and ePLND. With higher pT, GG, and presence of R1, the probability of BR increased. Those with pN1 (pathologicaly confirmed positive lymph nodes) were not associated with bRFS, with a pN1 detection rate of 3.9%.
Details: In low-risk PCa, curative treatment with RP can be performed, reporting a bRFS rate at 5 and 7 years of 90.1% and 88.3%, respectively. Despite the fact that pelvic lymphadenectomy is not recommended during RP in clinical guidelines, in the literature, it is performed in 34% of these patients, finding 0.37% of N1. In this study, we report the 10-year bRFS in patients with low-risk PCa who underwent surgery.
Collapse
Affiliation(s)
| | - José Gustavo Ramos
- Department of Urology Oncology, National Cancer Institute of Colombia, Bogotá, Colombia
| | - Luis Miguel Becerra
- Department of Urology Oncology, National Cancer Institute of Colombia, Bogotá, Colombia
| | - Rodolfo Varela
- Department of Urology Oncology, National Cancer Institute of Colombia, Bogotá, Colombia
- National University of Colombia, Bogotá, Colombia
| |
Collapse
|
8
|
Mosquera AV, Barco-Castillo C, Camacho D, Correa J, Varela R, Citarella D, Cabrera M. Radical Nephrectomy in Renal Cell Carcinoma with Venous Tumoral Thrombus: Long-term Outcomes and Overall Survival. Revista Urología Colombiana / Colombian Urology Journal 2022. [DOI: 10.1055/s-0042-1748871] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
Abstract
Objective To describe the five-year overall survival (OS) and perioperative morbidity of patients with renal cell carcinoma (RCC) with venous tumor thrombus (VTT) treated through radical nephrectomy and thrombectomy.
Materials and Methods We evaluated a cohort of 530 patients with a diagnosis of RCC from January 2009 to December 2019, and found VTT in 42 of them; these 42 patients composed the study sample. The patients were stratified according to the Neves Thrombus Classification (NTC). The baseline and perioperative characteristics, as well as the follow-up, were described. The Kaplan-Meier curve and its respective Cox regression were applied to present the 5-year OS and the OS stratified by the NTC.
Results The average age of the sample was of 63.19 ± 10.7 years, and there were no differences regarding gender. In total, VTT was present in 7.9% of the patients. According to the NTC, 30.9% of the cases corresponded to level I, 21.4%, to level II, 26.1%, to level III, and 21.4%, to level IV. The 5-year OS was of 88%. For level-I and level-II patients, the 5-year OS was of 100%, and of only 38% among level-IV patients. Complications, mostly minor, occurred in 57% of the cases.
Conclusions Radical nephrectomy with thrombectomy is a morbid procedure; however, most complications are minor, and the five-year mortality is null for patients in NTC levels I and II, and low for levels III and IV, and it may be even lower in level-III patients when standardizing transesophageal echocardiogram intraoperatively and routinary extracorporeal bypass. Thus, we recommend considering this surgery as the first-line management in patients with RCC and VTT.
Collapse
Affiliation(s)
- Aysa Vanessa Mosquera
- Department of Urology, Hospital Militar Central, Bogotá DC, Colombia and Universidad Militar Nueva Granada School of Medicine, Urology Residency Program, Bogotá DC, Colombia
| | - Catalina Barco-Castillo
- Department of Urology, Hospital Militar Central, Bogotá DC, Colombia and Universidad Militar Nueva Granada School of Medicine, Urology Residency Program, Bogotá DC, Colombia
| | - Diego Camacho
- Universidad Nacional School of Medicine, Bogotá DC, Colombia
- Department of Urology, Fundación Clínica Shaio, Bogotá DC, Colombia
| | - José Correa
- Universidad del Rosario School of Medicine, Bogotá DC, Colombia
| | - Rodolfo Varela
- Universidad Nacional School of Medicine, Bogotá DC, Colombia
- Department of Urology, Fundación Clínica Shaio, Bogotá DC, Colombia
- Facultad de Medicina, Universidad Nacional de Colombia, Bogotá DC, Colombia
| | - Danilo Citarella
- Department of Urology, Hospital Militar Central, Bogotá DC, Colombia and Universidad Militar Nueva Granada School of Medicine, Urology Residency Program, Bogotá DC, Colombia
- Department of Urology, Fundación Clínica Shaio, Bogotá DC, Colombia
| | - Marino Cabrera
- Universidad Nacional School of Medicine, Bogotá DC, Colombia
- Department of Urology, Fundación Clínica Shaio, Bogotá DC, Colombia
- Department of Urology, Fundación Clínica Shaio, Bogotá DC, Colombia
| |
Collapse
|
9
|
Brassetti A, Cozzi G, Gavrilov P, Chavarriaga Soto J, Bove A, Anceschi U, Ferriero M, Mastroianni R, Misuraca L, Tuderti G, Musi G, De Cobelli O, Breda A, Gaya Sopena J, Camacho D, Varela R, Simone G. Inguinal lymph node dissection for penile cancer: Results of a minimally invasive approach from a multicenter database. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00766-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
10
|
Acosta-Vega NL, Varela R, Mesa JA, Garay J, Baddoo MC, Gómez-Gutiérrez A, Serrano-Gómez SJ, Serrano ML, Zabaleta J, Combita AL, Sanabria-Salas MC. Abstract PO-136: Major signaling pathways associated with biochemical recurrence in Hispanic/Latino patients with prostate cancer. Cancer Epidemiol Biomarkers Prev 2022. [DOI: 10.1158/1538-7755.disp21-po-136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Abstract
Purpose. A high number of diagnosed prostate cancer (PCa) tumors are indolent and will never become aggressive during a patient's lifetime, however, about 20%-40% will experience post-operative disease relapse with biochemical recurrence (BCR), and a fraction of these will progress towards metastatic disease, which is the leading cause of PCa death. Reliable biomarkers helping in management decision-making and avoiding resistant PCa are still needed. We aimed to identify differentially expressed genes (DEGs) associated with BCR in localized PCa and to explore their involvement in signaling pathways contributing to the progression of PCa in Hispanic/Latino patients. Methods. A total of 117 Hispanic/Latino cases with localized PCa were included. RNA was extracted from FFPE tissues of radical prostatectomy (RP), RNA-seq was performed in 75 cases and used to identify DEGs between BCR positive (BCR) and BCR negative (non-BCR) cases. Signaling pathway analysis was done in MetaCore and DAVID database. DEGs with a p-value < 0.1 were used for enrichment analysis. Results. We identified 21 DEGs between BCR and non-BCR cases, three upregulated and 19 downregulated. From the enriched pathway maps found through MetaCore, the most remarkable pathways related with BCR included metabolism of androgen hormones; differentiation, self-renewal and maintenance of stem cells; mechanisms operating in type 2 diabetes (T2DM) and the cooperative action by pioglitazone and rosiglitazone with metformin; and metabolism of triacylglycerol. In line with these findings, results from DAVID also found Diabetes mellitus as one of the keywords, with downregulation of adiponectin (ADIPOQ) and MCF2L2 as the main genes related to this pathway. Other studies have shown that, regardless of BMI, individuals with T2DM have lower plasma adiponectin levels, which, in turn, are associated with pathophysiological conditions such as obesity, metabolic syndrome and insulin resistance. In our study, BMI was not associated with BCR, however, other complementary measurements related to increased abdominal fat (e.g., waist circumference or waist-to-hip ratio), and with recent evidence of strong association with aggressive PCa, were not assessed by us. Additional pathways associated with BCR progression were those related to biosynthesis and metabolism of androgens, being AKR1C the main gene involved. This gene participates in alternative pathways of the biosynthesis of androgens; for example, downregulated AKR1C leads to the synthesis of dihydrotestosterone and circumvents testosterone as a precursor. Conclusions. Enrichment analyses suggest that pathways related to T2DM and metabolism of androgens are main drivers of BCR in Hispanic/Latino PCa patients, mainly through the downregulation of ADIPOQ and AKR1C. Our findings confirm recent discoveries in the molecular understanding of PCa progression, but more studies analyzing abdominal fat measures in independent and larger cohorts could lead as to more precise conclusions, as well as to identify potential biomarkers and therapeutic targets.
Citation Format: Natalia L. Acosta-Vega, Rodolfo Varela, Jorge Andrés Mesa, Jone Garay, Melody C. Baddoo, Alberto Gómez-Gutiérrez, Silvia J. Serrano-Gómez, Martha Lucía Serrano, Jovanny Zabaleta, Alba L. Combita, María Carolina Sanabria-Salas. Major signaling pathways associated with biochemical recurrence in Hispanic/Latino patients with prostate cancer [abstract]. In: Proceedings of the AACR Virtual Conference: 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2021 Oct 6-8. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr PO-136.
Collapse
Affiliation(s)
- Natalia L. Acosta-Vega
- 1Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia. Programa de doctorado en Ciencias Biológicas, Pontificia Universidad Javeriana., Bogotá, Colombia,
| | - Rodolfo Varela
- 2Departamento de Urología, Instituto Nacional de Cancerología de Colombia, Bogotá, Colombia,
| | - Jorge Andrés Mesa
- 3Departamento de Patología Oncológica, Instituto Nacional de Cancerología de Colombia, Bogotá, Colombia,
| | - Jone Garay
- 4Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA,
| | | | - Alberto Gómez-Gutiérrez
- 6Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia,
| | - Silvia J. Serrano-Gómez
- 7Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, Colombia,
| | - Martha Lucía Serrano
- 7Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, Colombia,
| | - Jovanny Zabaleta
- 8Departments of Integrative Oncology and Pediatrics, Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA
| | - Alba L. Combita
- 7Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, Colombia,
| | | |
Collapse
|
11
|
Chavarriaga J, Camacho D, Suso-Palau D, Godoy F, Cabrera M, Forero J, López-de-Mesa B, Varela R. Inguinal lymph node density as a powerful predictor of cancer specific survival in patients with node-positive penile cancer. Urol Oncol 2021; 39:839.e1-839.e8. [PMID: 34400069 DOI: 10.1016/j.urolonc.2021.07.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Revised: 06/07/2021] [Accepted: 07/14/2021] [Indexed: 10/20/2022]
Abstract
INTRODUCTION Penile cancer (PC) is an aggressive malignancy in which the most important prognostic factor for cancer specific survival (CSS) is the involvement of regional lymph nodes (LNs). Lymph node density (LND) could become a superior prognostic tool for CSS, by accounting for both extent of dissection and nodal disease burden. We aim to validate LND as a prognostic factor for CSS in a contemporary series of patients with PC treated and followed at a single high-volume center, treating more than 25 PC patients per year, over a 13-year period. METHODS Clinical charts of all patients with PC who underwent surgical treatment between 2007 and 2020 were reviewed. Clinicopathological data was collected and analyzed retrospectively. We only included patients with ≥ 8 LNs removed in a unilateral ILND or ≥16 LNs when a bilateral approach was used. We attempted to find an optimal threshold for LND, capable of maximizing effect difference in terms of CSS and RFS between dichotomized groups. To determine this threshold, we used the chi-squared and the Mann-Whitney tests, and it was required to fulfill the proportional hazards assumption. We assessed different thresholds previously reported in the literature. In our study the optimal threshold for LND was determined to be ≤ 20% Descriptive statistics were used to summarize patient characteristics, CSS and RFS were graphically represented by Kaplan-Meier estimates. Harrell's C index for CSS and RFS were calculated for LND and pN stage, to determine which variable has a superior predictive capacity RESULTS: We identified 110 patients with PC who underwent ILND at our institution, of these, 87 were node-positive and were included in the final analysis. Overall estimates of CSS showed a 3-year CSS of 43% (95% CI: 32-54), the estimated 3-year CSS for the patients with a LND ≤ 20% was 69% (95% CI: 50-82) and 26% (95% CI: 14-39) in the group with a LND >20% (Log-rank P = 0.001). The estimated 3-year RFS for the patients with LND ≤ 20% was 61% (95% CI: 42-76) and 30% (95% CI: 16-44) in the group with a LND >20% (Log-rank P = 0.009). The results of univariate analysis indicate that in patients with a LND >20% the risk for cancer specific mortality was increased (HR 2.68; 95% CI: 1.45-4.98, P = 0.002) compared with LND ≤ 20%. In the and Cox multivariate analysis after Adjusting for age and pN stage the association increased (HR 2.73; 95%, CI 1.38-5.40, P = 0.004). Harrell´s C index for CSS was 0.63 for LND vs. 0.54 for pN stage, suggesting a 9% higher concordance for LND and CSS. CONCLUSIONS Lymph node density stands as a promising tool for risk-stratifying patients with node-positive PC after ILND. In this retrospective study, LND was a significant predictor of CSS and RFS when using a LND >20% threshold, and also showed a superior predictive ability than pN stage. These results support the use of the LND parameter in clinical practice with a final goal to improve risk stratification, and individualized adjuvant treatment decision-making to patients with high-risk of cancer specific mortality.
Collapse
Affiliation(s)
- Julian Chavarriaga
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia; Division of Urology, Clínica Imbanaco -Grupo Quirón Salud. Cali, Colombia; Division of Urology, Pontificia Universidad Javeriana. Bogotá, Colombia.
| | - Diego Camacho
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Daniel Suso-Palau
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Fabián Godoy
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Marino Cabrera
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Jorge Forero
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Byron López-de-Mesa
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Rodolfo Varela
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| |
Collapse
|
12
|
Chavarriaga J, Pardo J, Suso-Palau D, Becerra L, Camacho D, Godoy F, Forero J, Cabrera M, López-de-Mesa B, Ramirez A, Varela R. Real World Data of Penile Cancer Treatment at a High-Volume Center in South America: Insights and Survival Trends. Urology 2021; 156:199-204. [PMID: 34310915 DOI: 10.1016/j.urology.2021.07.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2021] [Revised: 06/28/2021] [Accepted: 07/14/2021] [Indexed: 11/19/2022]
Abstract
OBJECTIVE To report survival trends and oncological outcomes of penile cancer surgically treated patients, at a high-volume center, treating more than 25 patients each year, in a high incidence country. METHODS Clinical charts of all patients that underwent surgical management for penile cancer were reviewed. The primary end points were cancer specific survival (CSS), progression-free survival, and local recurrence free survival. Kaplan-Meier plots were used for survival analyses. Multivariate analysis was performed using cox proportional hazard age-adjusted models to determine the effect of pN, pT, lymphovascular invasion for CSS. RESULTS A total of 209 patients were identified, with a median follow up of 96 months (IQR 49-133). Organ-sparing surgerywas performed in 72.7%, 56.9% underwent dynamic sentinel lymph node biopsy, 110 patients underwent inguinal lymph node dissection, and 45 (21.5%) pelvic lymph node dissection. A total of 75 (35.8%) of patients relapsed, median time to relapse of 12 months (IQR 6-25). Overall estimates of CSS showed an 8-year CSS of 68.9%. Eight-year CSS was 90.5% for N0, and 32.8% in pN3 (P <.001). The Cox proportional hazard model showed that pN1-3, pT2-4, lymphovascular invasion and positive dynamic sentinel lymph node biopsy were the variables associated with worse 8-year CSS. CONCLUSION To the best of our knowledge, we report one of the largest cohorts on the survival outcomes of penile cancer surgical treatment, in a single institution, over a long period of time, were most patients are referred with high-risk, locally advanced or nodal disease.
Collapse
Affiliation(s)
- Julián Chavarriaga
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia; Division of Urology, Clínica Imbanaco, Grupo Quirón Salud. Cali, Colombia; Division of Urology, Pontificia Universidad Javeriana. Bogotá, Colombia.
| | - Julián Pardo
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Daniel Suso-Palau
- Division of Urology, Clínica Imbanaco, Grupo Quirón Salud. Cali, Colombia
| | - Luis Becerra
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Diego Camacho
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Fabián Godoy
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Jorge Forero
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Marino Cabrera
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Byron López-de-Mesa
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Angie Ramirez
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| | - Rodolfo Varela
- Department of Urologic Oncology, Instituto Nacional de Cancerología. Bogotá, Colombia
| |
Collapse
|
13
|
Chavarriaga J, Becerra LM, Camacho D, Godoy F, Varela R. Renal fossa recurrence with synchronous port site and appendicular metastases after laparoscopic nephrectomy: Role of metastases and abdominal wall en bloc resection. Urol Case Rep 2021; 38:101681. [PMID: 33996494 PMCID: PMC8099734 DOI: 10.1016/j.eucr.2021.101681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2021] [Revised: 04/09/2021] [Accepted: 04/11/2021] [Indexed: 11/21/2022] Open
Abstract
Isolated renal fossa recurrence and port site metastasis after laparoscopic nephrectomy are two different entities, and despite being rare, in selected cases would benefit from surgical resection. We report the case of a 61-year-old male with local renal fossa recurrence with synchronous metastasis involving the port site, the abdominal wall and the appendix, which was successfully treated with open surgical resection and is free of metastasis or recurrence. To conclude opportune treatment of similar cases, remain a safe and curative option, and should be considered after reviewing the case within a multidisciplinary team.
Collapse
Affiliation(s)
- Julián Chavarriaga
- Division of Urology, Pontificia Universidad Javeriana, Bogotá, Carrera 7 # 40-62, Colombia.,Department of Urologic Oncology, Instituto Nacional de Cancerologia, Bogotá, Colombia
| | - Luis Miguel Becerra
- Department of Urologic Oncology, Instituto Nacional de Cancerologia, Bogotá, Colombia
| | - Diego Camacho
- Department of Urologic Oncology, Instituto Nacional de Cancerologia, Bogotá, Colombia
| | - Fabián Godoy
- Department of Urologic Oncology, Instituto Nacional de Cancerologia, Bogotá, Colombia
| | - Rodolfo Varela
- Department of Urologic Oncology, Instituto Nacional de Cancerologia, Bogotá, Colombia
| |
Collapse
|
14
|
Valadas M, Freitas RM, Varela R. Psychiatric manifestations of autoimmune encephalitis. Eur Psychiatry 2021. [PMCID: PMC9476050 DOI: 10.1192/j.eurpsy.2021.1265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
IntroductionAutoimmune encephalitis (AE) refers to a newly described, heterogeneous group of rare diseases characterized by brain inflammation and circulating autoantibodies. Various AE have been described and each of them is linked to the presence of specific autoantibodies directed against synaptic and neuronal cell surface antigens. The clinical picture includes a wide array of neuropsychiatric symptoms and is correlated with the associated antibody subtype. Since pronounced psychiatric symptoms are relatively common at the onset, patients can be misdiagnosed and initially driven to psychiatric institutions, thus delaying the adequate diagnosis and management of AE.ObjectivesWe aim to review and summarize the psychiatric manifestations of AE that might dominate the clinical picture. We also aim to describe the clinical signs that should alert the psychiatrist to the possibility of these diagnoses.MethodsWe performed an updated review in the PubMed database using the terms “autoimmune”, “encephalitis” and “psychiatric manifestations”. The included articles were selected by title and abstract. We also consulted a reference textbook.ResultsWe summarize the reported psychiatric manifestations of AE and also include two situations that can be helpful in AE diagnosis in the psychiatric setting: symptoms that should alert the physician for the possibility of AE and symptoms that should prompt an antibody detection test.ConclusionsAE are rare diseases that present very frequently with psychiatric symptoms as the first manifestation. Psychiatrists need to be aware of the most common psychiatric manifestations of AE since the early recognition and treatment of AE is fundamental for a good outcome.
Collapse
|
15
|
Segura-Moreno YY, Sanabria-Salas MC, Varela R, Mesa JA, Serrano ML. Decoding the heterogeneous landscape in the development prostate cancer. Oncol Lett 2021; 21:376. [PMID: 33777200 PMCID: PMC7988715 DOI: 10.3892/ol.2021.12637] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2020] [Accepted: 06/02/2020] [Indexed: 01/02/2023] Open
Abstract
Prostate cancer (PCa) is characterized as being histologically and molecularly heterogeneous; however, this is not only incorrect among individuals, but also at the multiple foci level, which originates in the prostate gland itself. The reasons for such heterogeneity have not been fully elucidated; however, understanding these may be crucial in determining the course of the disease. PCa is characterized by a complex network of chromosomal rearrangements, which simultaneously deregulate multiple genes; this could explain the appearance of exclusive events associated with molecular subtypes, which have been extensively investigated to establish clinical management and the development of therapies targeted to this type of cancer. From a clinical aspect, the prognosis of the patient has focused on the characteristics of the index lesion (the largest focus in PCa); however, a significant percentage of patients (11%) also exhibit an aggressive secondary foci, which may determine the prognosis of the disease, and could be the determining factor of why, in different studies, the classification of the subtypes does not have an association with prognosis. Due to the aforementioned reasons, the analysis of molecular subtypes in several foci, from the same individual could assist in determining the association between clinical evolution and management of patients with PCa. Castration-resistant PCa (CRPC) has the worst prognosis and develops following androgen ablation therapy. Currently, there are two models to explain the development of CRPC: i) The selection model and ii) the adaptation model; both of which, have been found to include alterations described in the molecular subtypes, such as Enhancer of zeste 2 polycomb repressive complex 2 subunit overexpression, isocitrate dehydrogenase (NAPD+)1 and forkhead box A1 mutations, suggesting that the presence of specific molecular alterations could predict the development of CRPC. This type of analysis could lead to a biological understanding of PCa, to develop personalized medicine strategies, which could improve the response to treatment thus, avoiding the development of resistance. Therefore, the present review discusses the primary molecular factors, to which variable heterogeneity in PCa progress has been attributed.
Collapse
Affiliation(s)
- Yenifer Yamile Segura-Moreno
- Cancer Biology Research Group, National Institute of Cancerology, Bogota 110411, Colombia.,Department of Chemistry, Faculty of Sciences, National University of Colombia, University City, Bogota 111321, Colombia
| | | | - Rodolfo Varela
- Department of Urology, National Institute of Cancerology, Bogota 110411, Colombia.,Department of Urology, National University of Colombia, University City, Bogota 111321, Colombia
| | - Jorge Andrés Mesa
- Department of Pathology, National Institute of Cancerology, Bogota 110411, Colombia
| | - Martha Lucia Serrano
- Cancer Biology Research Group, National Institute of Cancerology, Bogota 110411, Colombia.,Department of Chemistry, Faculty of Sciences, National University of Colombia, University City, Bogota 111321, Colombia
| |
Collapse
|
16
|
Torres L, Ramos JG, Varela R, Cabrera M, Orrego PA, Mosquera AV, Vecino SVP. Complicaciones de la linfadenectomía retroperitoneal postquimioterapia en pacientes con tumor germinal de origen testicular: Experiencia de 12 años en un centro de referencia en Colombia. Rev Urol 2021. [DOI: 10.1055/s-0040-1721327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
Abstract
Resumen
Objetivo El objetivo de este estudio, fue describir las complicaciones intraoperatorias y postoperatorias, así como la necesidad de cirugías concomitantes en la linfadenectomía retroperitoneal postquimioterapia en un centro de referencia de manejo de cáncer.
Métodos Se recolectaron datos de una cohorte retrospectiva de pacientes con diagnóstico de tumor germinal de origen testicular que hubiesen recibido quimioterapia y en quienes se documentó tumor residual retroperitoneal y fueron sometidos a LRP-PC durante 12 años en un centro de referencia de manejo de cáncer.
Resultados Se practicó LRP-PC a 64 pacientes. La edad promedio al momento de la cirugía fue 28,1 años (18-47 años). El tamaño promedio de la masa retroperitoneal post quimioterapia fue 6,7 (1–28 cm). La estancia hospitalaria promedio fue 7,9 días (rango 1-99 días), la tasa de cirugías adicionales fue del 20%. La tasa de complicaciones mayores fue de 7,8%. Tener seminoma en la histología testicular inicial se asoció con un mayor sangrado y el tamaño de la masa retroperitoneal residual se asoció con la necesidad de cirugías concomitantes.
Conclusiones La LRP-PC es una cirugía de alto nivel de complejidad que se asocia a complicaciones mayores y a la necesidad de cirugías concomitantes. Esta cohorte de pacientes muestra desenlaces similares a los descritos en la literatura, recalcando el hecho de que esta cirugía, debería ser realizada en centros de referencia de manejo del cáncer.
Collapse
Affiliation(s)
- Lynda Torres
- Pontificia Universidad Javeriana, Centro Policlínico Olaya, Bogotá, Colombia
| | | | | | | | | | | | | |
Collapse
|
17
|
Torres L, Ramos JG, Varela R, Godoy F, Orrego PA, Mosquera A, Vecino SVP. Factores asociados a la histología de masa residual retroperitoneal post quimioterapia en tumor testicular de células germinales. Rev Urol 2020. [DOI: 10.1055/s-0040-1721357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Resumen
Objetivo El objetivo de este estudio es describir las características y factores relacionados con la histología de la masa residual postquimioterapia en pacientes con tumor de células germinales de origen testicular sometidos a linfadenectomía retroperitoneal durante 12 años de seguimiento.
Métodos Retrospectivamente se recolectaron datos clínicos, quirúrgicos y patológicos de la historia clínica de los pacientes en un centro de referencia de manejo de cáncer durante un periodo de 12 años. Se estimó la asociación entre los datos recolectados con la histología del tumor residual post quimioterapia.
Resultados Se incluyeron 64 pacientes, la edad promedio fue 28.1 años, el tamaño promedio de masa residual fue de 6.7 cm. La histología de la masa residual fue teratoma en 60.9%, necrosis 26.5% y tumor viable 12.5%. El grupo pronóstico tiene asociación con la histología de la masa retroperitoneal. Las masas con histología de necrosis tuvieron menor tamaño con media 6.5 cm mientras que otras histologías tuvieron tamaño promedio de la masa residual de 10.4 cm.
Conclusiones La LNDRP-PC es el estándar de tratamiento en masas residuales retroperitoneales después de quimioterapia y puede generar sobre-tratamiento hasta en 50% de los casos. El teratoma en la histología testicular está relacionado mayor tamaño de la masa residual retroperitoneal. Las características histológicas de la masa residual son comparables con otras series.
Collapse
Affiliation(s)
- Lynda Torres
- Médica Uróloga. Pontificia Universidad Javeriana, Bogotá, Colombia
| | - Jose Gustavo Ramos
- Médico Urólogo, Urología Oncológica, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Rodolfo Varela
- Médico Urólogo, Urología Oncológica, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Fabian Godoy
- Médico Urólogo, Urología Oncológica, Instituto Nacional de Cancerología, Bogotá, Colombia
| | | | | | | |
Collapse
|
18
|
Varela R, Rodríguez-Díaz L, deCastro M. Persistent heat waves projected for Middle East and North Africa by the end of the 21st century. PLoS One 2020; 15:e0242477. [PMID: 33201909 PMCID: PMC7671526 DOI: 10.1371/journal.pone.0242477] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2020] [Accepted: 11/04/2020] [Indexed: 11/19/2022] Open
Abstract
The duration and intensity of future heat waves are analyzed for 53 cities in the Middle East and the North Africa (MENA) region for the 21st century under two different scenarios (RCP4.5 and RCP8.5). A consistent approach is carried out using data from 13 Regional models within the framework of the Coordinated Regional Climate Downscaling Experiment (CORDEX). By the end of the century, 80% of the most populated MENA cities are expected to be at least 50% of the days under heat wave conditions during the warm season. In addition, the mean and maximum intensity of the heat waves will also increase. Changes in the duration and intensity of heat waves have shown to be negatively correlated. Therefore, the vulnerability of the MENA cities to future heat waves was determined using a cumulative index (CI) that takes into account both duration and intensity. This CI indicates that Middle East and the eastern part of Africa will suffer the most unfavorable temperature conditions in the future. Assuming no intervention trough adaptation/mitigation strategies, these results, together with the particular properties of the MENA region, such as aridity or lack of precipitation, make it likely that the area will be affected by disease or famine.
Collapse
Affiliation(s)
- R. Varela
- Environmental Physics Laboratory (EphysLab), CIM-UVIGO, Universidade de Vigo, Ourense, Spain
| | - L. Rodríguez-Díaz
- Environmental Physics Laboratory (EphysLab), CIM-UVIGO, Universidade de Vigo, Ourense, Spain
| | - M. deCastro
- Environmental Physics Laboratory (EphysLab), CIM-UVIGO, Universidade de Vigo, Ourense, Spain
| |
Collapse
|
19
|
Vega NLA, Varela R, Mesa JA, Garay J, Baddoo M, Zabaleta J, Combita-Rojas AL, Sanabria-Salas MC. Abstract 1503: Molecular subtypes in prostate cancer with differential prognosis and tumor biology in Hispanic patients. Cancer Res 2020. [DOI: 10.1158/1538-7445.am2020-1503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose: Clinical progression of localized prostate cancer (PCa) is highly variable mainly because of its multifocality and heterogeneity nature. Recent advances in emerging techniques have allowed to explore the molecular basis of PCa allowing the identification of molecular subtypes for primary PCa based on genetic alterations. The most prevalent subtype harbors rearrangements between the androgen-regulated promoter of TMPRSS2 with a member of the ETS family of transcription factors, the oncogene ERG, present in about 40%-50% of cases, and leading to increased expression of ERG. Here, we characterized the two main molecular subtypes, tumors overexpressing ERG and tumors with downregulated ERG, in localized PCa from Hispanic patients and determined the association of these subtypes with the prognosis of biochemical recurrence (BCR).
Methods: A total of 89 Hispanic cases with localized PCa were included. RNA from formalin-fixed paraffin-embedded tissues of radical prostatectomy (RP) was extracted and sequenced. We made differential expression analysis between ERGhigh and ERGlow cases and significant genes were submitted to MetaCore for enrichment analysis. Association with clinical and pathological variables was done and the impact of ERG subtypes on prognosis was determined by Kaplan-Meir analysis, Log-rank test and Cox proportional hazard regression, taking 5-year BCR-free survival as the event.
Results: Comparison between ERGhigh and ERGlow tumors showed 150 differentially expressed genes (DEGs) that revealed enriched pathways related with the angiotensin system and its signal transduction, Notch and NF-κB pathways, Beta-catenin-dependent transcription regulation in colorectal cancer, mTORC1 upstream signaling, linoleic acid metabolism, and polyamine metabolism. The renin-angiotensin system is implicated in PCa development since it activates MAPK, STAT3 and VEGF, ultimately stimulating proliferation and formation of blood vessels. ERGlow demonstrated to be associated with higher Gleason Grade Groups at RP and with BCR, and log-rank test showed correlation with worse BCR-free survival within 5-years after RP, while ERGhigh subtype presented a better BCR-free survival.
Conclusions: Our analysis illustrates different signaling pathways between the two main molecular subtypes in PCa, ERGhigh and ERGlow, which associates with different prognosis in Hispanic patients with localized PCa.
Citation Format: Natalia Lizeth Acosta Vega, Rodolfo Varela, Jorge A. Mesa, Jone Garay, Melody Baddoo, Jovanny Zabaleta, Alba L. Combita-Rojas, María C. Sanabria-Salas. Molecular subtypes in prostate cancer with differential prognosis and tumor biology in Hispanic patients [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 1503.
Collapse
Affiliation(s)
- Natalia Lizeth Acosta Vega
- 1Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, Colombia
| | - Rodolfo Varela
- 2Clínica de Urología, Subdirección General de Atención Médica y Docencia, Instituto Nacional de Cancerología de Colombia, Bogotá, Colombia
| | - Jorge A. Mesa
- 3Grupo de Patología Oncológica, Subdirección General de Atención Médica y Docencia, Instituto Nacional de Cancerología de Colombia, Bogotá, Colombia
| | - Jone Garay
- 4Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA
| | - Melody Baddoo
- 5Tulane University School of Medicine, New Orleans, LA
| | - Jovanny Zabaleta
- 4Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA
| | - Alba L. Combita-Rojas
- 1Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, Colombia
| | - María C. Sanabria-Salas
- 6Subdireccion de Investigaciones, Instituto Nacional de Cancerología de Colombia, Bogotá, Colombia
| |
Collapse
|
20
|
Ramos JG, Ramírez A, Varela R, Robledo D, De la Hoz-Valle J, Vargas R, Forero J, Godoy F, Cabrera M, Ochoa C, López B, Donoso W, Giraldo S, Pinzón C, Peralta S, Calderón A. Prognostic Factors for Inguinal Lymph Node Involvement and Tumor Recurrence in Squamous Cell Carcinoma of the Penis. Revista Urología Colombiana / Colombian Urology Journal 2020. [DOI: 10.1055/s-0039-1697997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Abstract
Abstract
Introduction Penile carcinoma is an aggressive disease with catastrophic consequences that frequently lead to death. Therefore, further knowledge on the prognostic factors that can help identify patients in need of more aggressive treatments becomes essential.
Objective To identify the prognostic factors for lymph node (LN) involvement and tumor recurrence in patients diagnosed with squamous cell carcinoma of the penis (SCCP).
Methods A retrospective cohort study was conducted. Patients diagnosed and treated for SCCP at Instituto Nacional de Cancerología between 2008 and 2015 were included in the sample. Cases in which no information on recurrence was available for the follow-up were excluded, as well as patients with no initial pathology and those getting penile reconstructions after cancer.Relevant data was retrieved from the medical records of each patient, and a descriptive analysis was performed. Subsequently, this data was used to apply a logistic regression model to determine the potential clinical and histopathological prognostic factors.
Results A total of 104 patients were included in the present study. The average age of the sample was 59 years, while the follow-up averaged 24 months per patient. Inguinal lymphadenectomy was performed on 61 patients (59%) during the follow-up. The logistic regression model showed that lymphovascular invasion (odds ratio [OR]: 6.7; 95% confidence interval [95%CI]: 1.2–35) and poor tumor differentiation (OR: 17; 95%CI: 3.2–92) were associated with tumor recurrence. Likewise, the lymphadenectomy procedures showed that lymphovascular invasion was associated with LN involvement (OR: 3.3; 95%CI: 1.1–10).
Conclusion Lymphovascular invasion was the strongest prognostic factor observed in our sample, aiding in the prediction of inguinal LN involvement and tumor recurrence in SCCP patients.
Collapse
Affiliation(s)
- J. Gustavo Ramos
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Angie Ramírez
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Rodolfo Varela
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Daniela Robledo
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - José De la Hoz-Valle
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Rafael Vargas
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Jorge Forero
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Fabián Godoy
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Marino Cabrera
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Claudia Ochoa
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Byron López
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Wilfredo Donoso
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Sergio Giraldo
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Carolina Pinzón
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Sara Peralta
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Andrés Calderón
- Department of Oncological Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| |
Collapse
|
21
|
López OL, Donoso WD, Barrios A, Varela R. Citología urinaria: ¿Qué sabemos? Urol Colomb 2019. [DOI: 10.1055/s-0038-1676314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Abstract
ResumenEl cáncer de vejiga es, en frecuencia, el segundo cáncer urológico y representa una mortalidad significativa. Es necesario entonces contar con herramientas diagnósticas efectivas que contribuyan a la toma de decisiones terapéuticas y de seguimiento. La citología urinaria es un método útil para dicho fin, pese a que es bien conocida su baja capacidad de identificación de tumores de bajo grado. Se ha demostrado cómo la citología urinaria es capaz de predecir la presencia de tumores uroteliales de alto grado que son, finalmente, aquellos que ameritan intervención pronta y ponen en riesgo la vida del paciente. Correctamente utilizada, la citología urinaria representa un apoyo fundamental en la toma de decisiones cuando el urólogo aborda el cáncer de vejiga.
Collapse
Affiliation(s)
| | - Wilfredo Donoso Donoso
- Urólogo, coordinador del postgrado de urología de la Universidad Nacional de Colombia, Colombia
| | | | - Rodolfo Varela
- Urólogo Oncólogo, profesor asociado de la Universidad Nacional de Colombia, Instituto Nacional de Cancerología, Bogotá DC, Colombia
| |
Collapse
|
22
|
Ramos JG, Jaramillo DC, Sandoval D, Gallego LJ, Riveros C, Sierra JA, Vargas I, López De Mesa López BE, Ibata L, Varela R. Diagnostic precision of sentinel lymph node biopsy in penile cancer. Indian J Urol 2019; 35:282-286. [PMID: 31619867 PMCID: PMC6792417 DOI: 10.4103/iju.iju_79_19] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Introduction: Sentinel lymph node biopsy (SLNB) was designed as a minimally invasive method for evaluation of nodal involvement in patients with penile cancer and nonpalpable lymph nodes. Nevertheless, SLNB is not used in a regular basis due to the lack of studies that adequately characterize the performance of this procedure. The purpose of this study was to evaluate the diagnostic performance of SLNB in patients with infiltrative penile carcinoma without palpable inguinal lymph nodes in a Colombian population. Materials and Methods: This is a retrospective observational study of 89 patients diagnosed with infiltrative penile squamous cell carcinoma with nonpalpable inguinal lymph nodes. These patients underwent partial or complete penectomy, along with SLNB, between 2008 and 2017. Those individuals with a positive SLNB underwent inguinal lymphadenectomy, while those with a negative SLNB were followed on a quarterly basis with a physical examination and imaging to assess relapse. Statistical analysis was done using the STATA 14 software. A contingency table was made to calculate sensitivity, specificity, positive predictive value, negative predictive value, and exactitude, each one with its own confidence interval (CI) of 95%. Results: There was an average follow-up of 31.4 months, and all 89 patients were evaluated; most primary tumors were T2 (55%), followed by T1 (37%), all of which were subclassified as T1b and T3 (8%). Tumours were most frequently located in the glans (43%). All patients were classified as cN0 and underwent SLNB. Sixty-one patients (69%) tested negative in the SLNB, four of whom (6%) presented with lymph node relapse. On the other hand, 28 patients (31%) tested positive in the SLNB and consequently underwent inguinal lymphadenectomy, seven of whom had negative lymph nodeinvolvement (25% false positives). According to the results, the sensitivity was 84% (95% CI, 65.3–93.6) and the specificity was 89% (95% CI, 79.4–94.7), with a false-negative rate of 6.5%. Conclusions: The SLNB using radiotracer can be a useful method for lymph node staging in patients with penile cancer and nonpalpable lymph nodes when performed in experienced centers.
Collapse
Affiliation(s)
- Jose Gustavo Ramos
- Department of Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | | | - David Sandoval
- Department of Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | | | - Carlos Riveros
- Department of Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | | | - Isis Vargas
- Department of Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | | | - Linda Ibata
- Department of Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Rodolfo Varela
- Department of Urology, Instituto Nacional de Cancerología, Bogotá, Colombia
| |
Collapse
|
23
|
Fuentes-Gandara F, Torres A, Fernández-Ponce M, Casas L, Mantell C, Varela R, Martínez de la Ossa-Fernández E, Macías F. Selective fractionation and isolation of allelopathic compounds from Helianthus annuus L. leaves by means of high-pressure techniques. J Supercrit Fluids 2019. [DOI: 10.1016/j.supflu.2018.08.004] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
24
|
Delgado N, Forero J, Varela R, Cabrera F M. Radioablación por laparoscopia de masas renales pequeñas en pacientes octogenarios: técnica paso a paso. Urol Colomb 2018. [DOI: 10.1055/s-0038-1656518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Abstract
Introducción La cirugía preservadora de nefronas sigue siendo el gold standard de manejo en pacientes con tumores renales pequeños. La ablación por radiofrecuencia es una alternativa mínimamente invasiva con evidencia sustancial en efectividad en la erradicación tumoral completa.
Objetivo Reportar el caso y la técnica paso a paso de la radioablación laparoscópica de un tumor renal en un centro de oncología de III nivel de Bogotá - Colombia.
Materiales y Métodos Revisión de la historia clínica de un paciente con hallazgo incidental de una masa renal pequeña sometido a radioablación laparoscópica en un centro de oncología de III nivel de Bogotá.
Conclusión La ablación por radiofrecuencia es una alternativa válida para el tratamiento de tumores renales pequeños, especialmente en adultos mayores y con alto riesgo quirúrgico, ofreciendo tasas de supervivencia libre de enfermedad comparables con la nefrectomía parcial.
Collapse
Affiliation(s)
- Natalia Delgado
- Postgrado de Urología, Fundación Universitaria Sanitas, Bogotá, Colombia
| | - Jorge Forero
- Departamento de Urología Oncológica, Instituto Nacional de Cancerología, Ciudad de México, Mexico
| | - Rodolfo Varela
- Departamento de Urología Oncológica, Instituto Nacional de Cancerología, Ciudad de México, Mexico
| | - Marino Cabrera F
- Departamento de Urología Oncológica, Instituto Nacional de Cancerología, Ciudad de México, Mexico
| |
Collapse
|
25
|
Bacaret W, Cabrera M, Ramos G, Varela R, Donoso W. Metástasis inusuales en carcinoma de células renales. Rev Urol 2018. [DOI: 10.1055/s-0038-1645860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
Introducción y Objetivos El carcinoma renal de células claras (CCR), es la neoplasia renal más frecuente. Hasta el 30% de los casos presentan enfermedad sistémica, siendo las más usuales: pulmón, ganglios, hígado y cerebro. El objetivo de este trabajo es informar casos poco frecuentes de metástasis por CCR y establecer posibles factores relacionados con las metástasis.
Métodos y Materiales revisión retrospectiva de historias clínicas en el instituto nacional de cancerología de los pacientes con carcinoma de células renales metastásico entre los años 2013 a 2017. Se identificaron 6 casos con sitios de metástasis inusuales en pacientes del servicio de urología oncológica del instituto nacional de cancerología, destacando histopatología e inmunohistoquímica de los especímenes quirúrgicos tanto del primario como de la metástasis, reportando marcadores específicos y clasificaciones según corresponda.
Resultados Caso 1 Metástasis a duodeno, Caso 2 metástasis a ovario, caso 3 metástasis a testículo, caso 4 metástasis a piel, caso 5 metástasis a glándula tiroides, caso 6 metástasis a mama y piel. Se evaluaron diferentes variables y se analizaron con base en la literatura.
Conclusiones Consideramos que la edad, el tabaquismo, el grado histológico, la invasión de la vena renal, el tamaño tumoral y el estadio pueden ser factores predisponentes para ese comportamiento.
Collapse
Affiliation(s)
- W. Bacaret
- Residente em Urología Universidad Nacional de Colombia, Bogotá, Colombia
| | - M. Cabrera
- Urólogo, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - G. Ramos
- Urólogo, Instituto Nacional de Cancerología, Bogotá, Colombia
| | - R. Varela
- Profesor Asociado de Urología, Universidad Nacional de Colombia, Bogotá, Colombia
| | - W. Donoso
- Profesor Asociado de Urología, Universidad Nacional de Colombia, Bogotá, Colombia
| |
Collapse
|
26
|
Acosta N, Zabaleta J, Varela R, Mesa J, Serrano S, Garay J, Baddoo M, Nataly C, Combita AL, Sanabria-Salas MC. Abstract B69: Aggressiveness and tumor biology in prostate cancer patients with and without biochemical recurrence. Cancer Epidemiol Biomarkers Prev 2018. [DOI: 10.1158/1538-7755.disp17-b69] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Abstract
Background: Prediction of biochemical recurrence (BCR) using standard measures to assign risk classification in prostate cancer (PCa) patients at diagnosis is not precise. While in some patients BCR may happen sooner than expected in others, it may take several years before it appears. It is then necessary to devise better tools to predict accurately BCR. Our goal was to identify differentially expressed genes (DEGs) in cases with and without BCR within the risk groups determined by D'Amico (defined by the clinical stage, initial PSA, and Gleason stage in biopsy).
Methods: We ran RNA-seq analysis in 52 Hispanic PCa patients with early BCR (within 5 years after the surgery) and 57 with no BCR in the same period of time. The cases were classified as high, intermediate, or low according to the D'Amico classification. Analyses were done using the DESeq2 package. Genes with p value adjusted by False Discovery Rate (padj) less than 0.05 and fold change (FC) > 2 were considered statistically significant. Pathway analysis was performed in MetaCore.
Results: We found 4,281 DEGs (padj < 0.05) associated with tumor tissues in the BCR cases (7 of those with a FC > 2). In contrast, 4,647 DEGs were associated with tumor tissues in cases without BCR (16 with FC > 2). Of these genes, nine (CHRM3, CLDN8, ERG, GDF15, LUZP2, OR51E1, PTPRT, TRGC1, TPO) were exclusively found in cases without BCR, and one, ONECUT2, was exclusive for tissues with BCR. All these genes, except TRGC1, have been associated before with PCa: the Cholinergic Receptor Muscarinic 3 (CHRM3) and the Olfactory Receptor Family 51 Subfamily E Member 1 (OR51E1) have a growth-promoting role; Claudin 8 (CLDN8) is transcriptionally activated by the androgen receptor to promote progression of PCa; ETS Trancription Factor (ERG) participates in chromosomal translocation in PCa and is involved in cell proliferation, differentiation, angiogenesis, inflammation, and apoptosis; Growth Differentiation Factor 15 (GDF15) was reported to be part of a circulating tumor cell profile in castration-resistant PCa with high levels associated with poor survival; Leucine Zipper Protein 2 (LUZP2) seems to contribute to enzalutamide resistance in castration-resistant PCa; Protein Tyrosine Phosphatase Receptor Type T (PTPRT) was recently found overexpressed in localized PCa; Thyroid Peroxidase (TPO) promotes resistance to cell death and to chemotherapy in PCa; and ONECUT2 has been associated with different types of cancer and recently with prostate cancer. Pathway analysis of DEGs identified IL-6 signaling pathway via MEK/ERK and PI3K/AKT cascades; PPAR pathway activation (which involves transcription factors belonging to the nuclear hormone receptor superfamily and activated by fatty acids); and Adenosine A2B receptor signaling, which indirectly activates c-Myc, Cyclin D1, PI3K/AKT, and IL-6 in patients with BCR. On the other hand, IL-15 signaling via JAK-STAT cascade, WNT signaling pathway, G-protein signaling, apoptosis, and survival through NGF/TrkA PI3K-mediating signaling and mTORC2 downstream signaling pathways were identified in the group without BCR. These differences show that DEGs in both groups, even though implicated in processes related with tumor development, are involved in specific pathways that can be associated with the grade of aggressiveness of the tumors, and also, under specific circumstances, lead to BCR. In addition, we found that DEGs can separate BCR from no BCR cases within each risk group, suggesting that a genomic signature with DEGs is a better predictor of BCR than the clinically assigned risk groups.
Conclusions: Tumor biology and signaling pathways activated in cases with BCR are different from those in cases without BCR, showing that aggressiveness of tumors can be found at the moment of surgery and that biomarkers of prognosis can be identified at this point.
Citation Format: Natalia Acosta, Jovanny Zabaleta, Rodolfo Varela, Jorge Mesa, Silvia Serrano, Jone Garay, Melody Baddoo, Cruz Nataly, Alba Lucía Combita, María Carolina Sanabria-Salas. Aggressiveness and tumor biology in prostate cancer patients with and without biochemical recurrence [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr B69.
Collapse
Affiliation(s)
- Natalia Acosta
- 1Instituto Nacional de Cancerología, Bogotá, Bogotá, D.C., Colombia,
| | - Jovanny Zabaleta
- 2Louisiana State University Health Sciences Center, New Orleans, LA,
| | - Rodolfo Varela
- 1Instituto Nacional de Cancerología, Bogotá, Bogotá, D.C., Colombia,
| | - Jorge Mesa
- 1Instituto Nacional de Cancerología, Bogotá, Bogotá, D.C., Colombia,
| | - Silvia Serrano
- 1Instituto Nacional de Cancerología, Bogotá, Bogotá, D.C., Colombia,
| | - Jone Garay
- 2Louisiana State University Health Sciences Center, New Orleans, LA,
| | | | - Cruz Nataly
- 1Instituto Nacional de Cancerología, Bogotá, Bogotá, D.C., Colombia,
| | | | | |
Collapse
|
27
|
Gómez Meza J, Varela R, Ramírez A. Eficacia y seguridad del dietiletilbestrol, en el tratamiento del cáncer de próstata resistente a la castración. Urol Colomb 2018. [DOI: 10.1055/s-0038-1639583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Abstract
Introducción y objetivos Existen múltiples opciones de tratamiento en pacientes con cáncer de próstata resistente a la castración, entre ellas el Dietilestilbestrol (DES) sin embargo, su uso es controversial. Este estudio tiene como objetivo determinar la eficacia y seguridad del DES, en el tratamiento de pacientes con cáncer de próstata resistente a la castración en nuestra población.
Métodos y Materiales Se realizó un estudio de corte transversal, incluyendo los pacientes con cáncer de próstata resistente a la castración que recibieron tratamiento con DES. Se realizó un análisis demográfico, bivariado, tomando como desenlace la respuesta del PSA (Ausente, Completa o Parcial), el tiempo medio de progresión del PSA y la presencia de eventos adversos asociados al medicamento.
Resultados Noventa y un pacientes incluidos al final del estudio. La distribución de respuesta del PSA fue así: Respuesta en 57 (63,7%) pacientes, (Completa 28% - 31,1% y parcial 29% - 32,2%). Ausente en 33 (36,7%) pacientes. El análisis bivariado no evidenció asociación entre las variables y los desenlaces propuestos. El tiempo medio de progresión del PSA fue de 10,43 meses (Log-rank p = 0.001), no se encontraron diferencias estadísticamente significativas para el tiempo medio a progresión en asociación con la respuesta al PSA (respuesta o ausente y la presencia de enfermedad metastásica), Log-rank p = 0,789, Log-rank p = 0,218, Log-rank p = 0,780 respectivamente. La tasa de complicaciones asociadas a DES fue del 4,4% y correspondió en todos los casos a trombosis venosa profunda.
Conclusiones El DES en pacientes con cáncer de próstata resistente a la castración continúa siendo una herramienta de tratamiento eficaz y con baja tasa de eventos adversos en nuestra población.
Collapse
Affiliation(s)
- Jorge Gómez Meza
- Departamento de Urología, Fundación Universitaria Sanitas, Clínica Universitaria Colombia, Bogotá, Colombia
| | - Rodolfo Varela
- Departamento de Urología, Jefe del servicio de Urología Oncológica, Instituto Nacional de Cancerología, Ciudad de México, CDMX, México
| | - Angie Ramírez
- Department of Medico General, Instituto Nacional de Cancerología, Bogotá, Colombia
| |
Collapse
|
28
|
Cabrera M, Ramos JG, Ochoa CL, Ramirez A, Varela R, Forero J, Godoy G. V6-11 LAPAROSCOPIC RADICAL HEMINEPHROURETECTOMY IN HORSESHOE KIDNEY WITH HIGH-GRADE UROTHELIAL CELL CARCINOMA AND SINGLE-PORT BLADDER CUFF MANAGEMENT: FIRST CASE REPORT. J Urol 2017. [DOI: 10.1016/j.juro.2017.02.1586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
29
|
Ochoa C, Ramirez A, Varela R, Godoy F, Vargas R, Forero J, Rojas A, Roa C, Céspedes C, Ramos J, Cabrera M, Calderon A. Metastasectomy of Abdominal Wall Lesions due to Prostate Cancer Detected Through PET/CT Gallium 68-PMSA: First Case Report. Urol Case Rep 2017; 12:42-44. [PMID: 28316937 PMCID: PMC5349454 DOI: 10.1016/j.eucr.2017.01.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2016] [Revised: 01/19/2017] [Accepted: 01/20/2017] [Indexed: 11/23/2022] Open
Abstract
Introducing the topic of abdominal wall metastasis secondary to prostate cancer with a reminder of the disease's rarity, being the first published case. This article is about a 66 year old patient diagnosed with prostate cancer [cT2aNxMx iPSA: 5,6 ng/ml Gleason 3+3, (Grade 1 Group)], treated with radical prostatectomy as well as accompanied with amplified pelvic lymphadenectomy, who subsequently presented metastatic lesions to the abdominal wall diagnosed with PET/CT Gallium 68-PMSA technique and treated with abdominal metastasectomy with adequate short term results.
Collapse
Affiliation(s)
- Claudia Ochoa
- Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Angie Ramirez
- Instituto Nacional de Cancerología, Bogotá, Colombia
| | | | - Fabian Godoy
- Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Rafael Vargas
- Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Jorge Forero
- Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Andres Rojas
- Instituto Nacional de Cancerología, Bogotá, Colombia
| | - Carmen Roa
- Instituto Nacional de Cancerología, Bogotá, Colombia
| | | | - Jose Ramos
- Instituto Nacional de Cancerología, Bogotá, Colombia
| | | | | |
Collapse
|
30
|
Acosta NL, Baddoo MC, Combita AL, Varela R, Mesa J, Sanabria-Salas MC, Zabaleta J. Abstract B56: RNA-seq analysis of prostate cancer samples from Hispanic patients reveal progressive characteristics in Gleason patterns. Cancer Epidemiol Biomarkers Prev 2017. [DOI: 10.1158/1538-7755.disp16-b56] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Abstract
Background. One of the prognostic markers widely used in clinic to predict survival in prostate cancer (PC) patients is the Gleason score. Differences have been observed in biochemical progression-free and overall survival in patients with different Gleason scores. Because each Gleason represents a different state of tumor progression, we decided to characterize expression profiles and pathways in Gleason 3, 4 and 5 in order to explore the tumor biology context in each pattern, and thus determine possible prognosis biomarkers in PC.
Methods. We extracted RNA from normal and malignant formalin-fixed paraffin-embedded tissues from radical prostatectomy samples of Colombian patients and analyzed expression using data generated with next generation sequencing methods. Pathway analysis was done with MetaCore.
Results. Eleven gene networks (7 genes) were common between all Gleason scores and represented cellular processes possibly involved with damage of the prostatic tissue including: cell adhesion, cytoskeleton remodeling and metabolism of phosphatidyl compounds. According to the analysis in Gleason pattern 3, the principal pathways were associated with cytoskeleton remodeling, gap junctions signaling and regulation of cell adhesion. These pathways could contribute to de-differentiation process experienced by cells towards tumor transformation in early stages of progression. Also, signaling of epithelial-to-mesenchymal transition (EMT) were observed, this findings could suggests not only cytoskeleton remodeling during de-differentiation, but also appearance of metastatic cells in this Gleason pattern. On the other hand, the action of the Androgen Receptor (AR) is suggested by protein-protein interactions characterized by rapid activation of signaling cascades of proliferation, cell growth and survival, via MAPK and PI3K/AKT. The latter in turn induces AR overexpression through control of regulatory protein MDM-2 and optimizes binding of AR to promoter/enhancer regions over its target genes. Also, AR inhibits WNT signaling via interaction with B-catenin. However, AR is a LEF-1/TCF transcriptional target, which is activated by WNT/B-catenin signaling.
The pathways identified in Gleason pattern 4 were similar to those of Gleason 3, with a more significant participation of pathways leading to cytoskeleton remodeling, regulation of cell adhesion molecules and of EMT. In addition, there is ligand-independent activation of AR, wherein activating mutations, splicing variants and activation by other signaling cascades, may lead to directed transactivation of target genes in a deregulated manner. Further, NGF/TrkA/PI3K-mediated signaling may lead to inhibition of apoptosis and survival of these cells.
Finally, pathways analysis in Gleason pattern 5 showed that the most significant was cell adhesion and ECM remodeling, which favors the metastatic process and regulation of cell motility and adhesion, processes aided by migration and angiogenesis signaling pathways. Likewise, AR activation and downstream signaling has an important role, transactivating transcription factors, which together lead to cell proliferation, inhibition of apoptosis, expression of tumor growth factors, regulation of cell adhesion molecules and from inflammatory response. The latter is reflected in another pathway identified, as is the antigen presentation by MHC class II.
Conclusion. The pathways identified by different Gleason patterns exhibit progression of localized prostate tumors into metastatic ones, where there is cell growth and dysregulation in signaling pathways at the beginning, and then, as they progress, they acquire the ability to migrate and to regulate AR signaling through different mechanisms so that allows AR to be a central regulator in PC.
Citation Format: Natalia L. Acosta, Melody C. Baddoo, Alba L. Combita, Rodolfo Varela, Jorge Mesa, Maria C. Sanabria-Salas, Jovanny Zabaleta. RNA-seq analysis of prostate cancer samples from Hispanic patients reveal progressive characteristics in Gleason patterns. [abstract]. In: Proceedings of the Ninth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2016 Sep 25-28; Fort Lauderdale, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2017;26(2 Suppl):Abstract nr B56.
Collapse
Affiliation(s)
- Natalia L. Acosta
- 1Instituto Nacional de Cancerologia, Bogota, Cundinamarca, Colombia,
| | - Melody C. Baddoo
- 2Tulane Cancer Center, Tulane University Medical School, New Orleans, Louisiana,
| | - Alba L. Combita
- 1Instituto Nacional de Cancerologia, Bogota, Cundinamarca, Colombia,
| | - Rodolfo Varela
- 1Instituto Nacional de Cancerologia, Bogota, Cundinamarca, Colombia,
| | - Jorge Mesa
- 1Instituto Nacional de Cancerologia, Bogota, Cundinamarca, Colombia,
| | | | - Jovanny Zabaleta
- 3Department of Pediatrics-Stanley S. Scott Cancer Center, LSUHSC, New Orleans, Louisiana
| |
Collapse
|
31
|
Varela R, Santos F, Gómez-Gesteira M, Álvarez I, Costoya X, Días JM. Influence of Coastal Upwelling on SST Trends along the South Coast of Java. PLoS One 2016; 11:e0162122. [PMID: 27606676 PMCID: PMC5015971 DOI: 10.1371/journal.pone.0162122] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2016] [Accepted: 08/17/2016] [Indexed: 11/18/2022] Open
Abstract
The south coast of Java has warmed at a much lower rate than adjacent ocean locations over the last three decades (1982-2015). This behavior can be observed during the upwelling season (July-October) and it is especially patent in August and September when upwelling attains the highest values. Although different warming rates (ocean-coast) had been previously observed in other areas around the world, this behavior was always linked to situations where upwelling increased or remained unchanged. South Java warming is observed at ocean locations and cooling near shore but under a scenario of decreasing upwelling (~30% in some cases). The origin of coastal cooling is due to changes in the vertical structure of the water column. A vein of subsurface water, which has cooled at a rate higher than 0.3°C per decade, is observed to enter from the northwestern part of the study area following the South Java Current. This water only manifests at surface near coast, where it is pumped up by coastal upwelling.
Collapse
Affiliation(s)
- R. Varela
- Ephyslab, Environmental Physics Laboratory, Facultad de Ciencias, Universidad de Vigo, 32004 Ourense, Spain
| | - F. Santos
- Ephyslab, Environmental Physics Laboratory, Facultad de Ciencias, Universidad de Vigo, 32004 Ourense, Spain
- CESAM, Departamento de Física, Universidade de Aveiro, 3810–193 Aveiro, Portugal
| | - M. Gómez-Gesteira
- Ephyslab, Environmental Physics Laboratory, Facultad de Ciencias, Universidad de Vigo, 32004 Ourense, Spain
| | - I. Álvarez
- Ephyslab, Environmental Physics Laboratory, Facultad de Ciencias, Universidad de Vigo, 32004 Ourense, Spain
- CESAM, Departamento de Física, Universidade de Aveiro, 3810–193 Aveiro, Portugal
| | - X. Costoya
- Ephyslab, Environmental Physics Laboratory, Facultad de Ciencias, Universidad de Vigo, 32004 Ourense, Spain
| | - J. M. Días
- CESAM, Departamento de Física, Universidade de Aveiro, 3810–193 Aveiro, Portugal
| |
Collapse
|
32
|
Vidal-Bralo L, Montes A, Varela R, Bόveda M, Pérez-Pampín E, Gόmez-Reino J, Gonzalez A. SAT0071 Number of Autoantibodies Associated with All-Cause Mortality in Patients with Rheumatoid Arthritis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.5605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
33
|
Ortiz AM, Fernández N, Villareal N, Vargas R, Varela R. Condrosarcoma mesenquimal peneano: primer reporte de caso. Urología Colombiana 2015. [DOI: 10.1016/j.uroco.2015.10.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
34
|
Varela R, Santelices JP, Cuzmar D, Aldunate JT, Plaza-Guzmán N, Lizama-Calvo P. [Vertebral hydatidosis: case report]. Acta Ortop Mex 2015; 29:110-113. [PMID: 27012085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Hydatidosis caused by echinococcus granulosus may affect any organ in the body, with the lungs and the liver as the most commonly affected organs. Vertebral compromise resulting from echinococcus granulosus has a low prevalence and accounts for less than 1% of bone compromise. We report the case of a 50 year-old female who presented at the Trauma Service with progressive low back pain with 5 months of duration that irradiated to the right lower limb, and led to neurologic compromise of the limb. Imaging studies showed spondylodiscitis at T12-L1, confirmed by a biopsy. Treatment of this condition is both orthopedic and surgical. The recurrence rate is high, between 30 and 40%. The objective of describing this case is to propose the differential diagnosis of a vertebral mass of unknown origin and provide details as to how to manage this condition.
Collapse
|
35
|
Aguado JM, Vazquez L, Fernandez-Ruiz M, Villaescusa T, Ruiz-Camps I, Barba P, Silva JT, Batlle M, Solano C, Gallardo D, Heras I, Polo M, Varela R, Vallejo C, Olave T, Lopez-Jimenez J, Rovira M, Parody R, Cuenca-Estrella M, Zarzuela MP, Candel Gonzalez FJ, Amador PM, Mediavilla JD, Camps IR, Barba P, Castillo N, Martin MT, Soriano JA, Fernando IH, Castilla-Llorente C, Cesteros R, Rodriguez Mondejar MR, Vazquez L, Villaescusa T, Caballero D, Garcia JE, Garcia IG, de la Mano Gonzalez S, Fernandez Garcia-Hierro JM, Solano C, Tormo M, Navarro D, Angel Molla M, Vallejo C, Gonzalez AJ, Gonzalez S, Gonzalez AP, Palomo P, Porras RP, Batlle M, Gallardo D, Guardia Sanchez R, Rosario Varela M, Olave Rubio MT, Jimenez JL, Tarrats MR, Grande MSL, Fernandez-Aviles F, Aguado JM, Fernandez-Ruiz M, Silva JT, Cuenca-Estrella M, Buitrago MJ, Amador TM, Bernal-Martinez L. Serum Galactomannan Versus a Combination of Galactomannan and Polymerase Chain Reaction-Based Aspergillus DNA Detection for Early Therapy of Invasive Aspergillosis in High-Risk Hematological Patients: A Randomized Controlled Trial. Clin Infect Dis 2014; 60:405-14. [DOI: 10.1093/cid/ciu833] [Citation(s) in RCA: 119] [Impact Index Per Article: 11.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
36
|
Kossioni AE, Lyrakos G, Ntinalexi I, Varela R, Economu I. The development and validation of a questionnaire to measure the clinical learning environment for undergraduate dental students (DECLEI). Eur J Dent Educ 2014; 18:71-9. [PMID: 24521086 DOI: 10.1111/eje.12051] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 03/15/2013] [Indexed: 05/25/2023]
Abstract
AIM The aim of this study was to develop and validate according to psychometric standards a self-administered instrument to measure the students' self-perceptions of the undergraduate clinical dental environment (DECLEI). MATERIALS AND METHODS The initial questionnaire was developed using feedback from dental students, experts' opinion and an extensive literature review. Critical incident technique (CIT) analysis was used to generate items and identify domains. Thirty clinical dental students participated in a pilot validation that generated a 67-item questionnaire. To develop a shorter and more practical version of the instrument, DECLEI-67 was distributed to 153 clinical students at the University of Athens and its English version to 51 students from various dental schools, attending the 2012 European Dental Students Association meeting. This final procedure aimed to select items, identify subscales and measure internal consistency and discriminant validity. RESULTS A total of 202 students returned the questionnaires (response rate 99%). The final instrument included 24 items divided into three subscales: (i) organisation and learning opportunities, (ii) professionalism and communication and (iii) satisfaction and commitment to the dental studies. Cronbach's α for the total questionnaire was 0.89. The interscale correlations ranged from 0.39 to 0.48. The instrument identified differences related to school of origin, age and duration of clinical experience. An interpretation of the scores (range 0–100) has been proposed. CONCLUSIONS The 24-item DECLEI seemed to be a practical and valid instrument to measure a dental school's undergraduate clinical learning environment.
Collapse
|
37
|
Restrepo-Gonzalez JA, Garcia-Perdomo HA, Varela R. Diagnostic accuracy of preoperative urinary smear test in patients with bladder urothelial carcinoma in a high-volume center. ARCH ESP UROL 2014; 67:243-248. [PMID: 24840589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
OBJECTIVES To determine diagnostic accuracy of urinary cytology (smear test) in patients with preoperative diagnosis of urothelial bladder carcinoma. METHODS Clinical records of the patients with urotelial bladder carcinoma at the Instituto Nacional de Cancerología (Bogotá D.C.,Colombia) from January 2006 to November 2010 were reviewed. Demographic data, pathological reports of preoperative cytology and definitive surgery, tumor classification and time between sample taking for cytology and final pathology were extracted. Descriptive statistics and graphs for continuous and categorical variables were performed. RESULTS We included 52 patients, 20 underwent cystectomy and 32 transurethral resection of the bladder tumor (TURB). 41 were male. Mean age was 66.6 ± 10.7 years. 151 smears were obtained before surgery, with a median of 3 smears performed per patient at 2.5 ± 1.8 months before definitive surgery. 107 were negative, 14 low grade positive and 30 high grade positive. The sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio and negative likelihood ratio were 30.7%, 90.9%, 97.7%, 9.34%, 3.37 and 0.76 respectively. When the high-grade cytology was compared with the high-grade definitive report some characteristics increased (Sensitivity 47.4%, Specificity: 97.8%, Positive Likelihood Ratio: 21.8) and also when compared with muscle invasion (Sensitivity: 73.9, Positive Likelihood Ratio: 7.27 ). CONCLUSION Preoperative cytology has sensitivity and specificity similar to those described in other clinical settings. Also noteworthy is that one high-grade preoperative cytology has a high positive likelihood ratio for high-grade tumor and invasive tumor (≥T2).
Collapse
Affiliation(s)
| | | | - Rodolfo Varela
- Servicio de Urologia.Instituto Nacional de Cancerologia. Bogota.Colombia
| |
Collapse
|
38
|
Kossioni AE, Varela R, Ekonomu I, Lyrakos G, Dimoliatis IDK. Students' perceptions of the educational environment in a Greek Dental School, as measured by DREEM. Eur J Dent Educ 2012; 16:e73-8. [PMID: 22251357 DOI: 10.1111/j.1600-0579.2011.00678.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
Abstract
AIM The aim of this study was to estimate the dental students' perceptions of their educational environment and to identify any differences related both to their gender and semester of studies. MATERIALS AND METHODS The translated and validated in Greek Dundee Ready Education Environment Measure (DREEM) questionnaire was distributed to all 2nd- to 5th-year students of the Athens Dental School. The questionnaire consisted of 50 statements organised in five subscales (perceptions of learning, teachers, atmosphere, academic self-perceptions and social self-perceptions). Internal validity was checked with Cronbach alpha. Confirmatory factor analysis (CFA) was performed under the same conditions as the original inventory. Mean statement, subscale and overall scores were calculated and given as percentages. RESULTS The response rate was 64%. Overall Cronbach alpha was 0.93 (excellent). CFA produced five meaningful subscales, not matching the original ones. The overall DREEM mean score was 56%. Gender did not influence the findings. The students' perceptions of the educational environment with the exception of the academic self-perceptions were more positive in the pre-clinical years. Statistically significant differences were revealed only for the 'learning' subscale between the 3rd- and the 4th-year students. Seventy-eight percent of the statements were in the positive side. The lowest scores were related to students' stress, tiredness and lack of appropriate feedback from the teachers, and the highest were related to accommodation, school friends and perceptions that they feel socially comfortable in class. CONCLUSIONS Students' perceptions of the educational environment were reasonably positive, with no gender difference. However, some weaknesses were identified, particularly in the clinical years. Further research is needed to clarify appropriate interventions.
Collapse
Affiliation(s)
- A E Kossioni
- University of Athens Dental School, Athens, Greece.
| | | | | | | | | |
Collapse
|
39
|
Varela R, García HA, Cortés V. Hemangiopericitoma testicular/tumor fibroso solitario: un caso poco frecuente. ARCH ESP UROL 2010. [DOI: 10.4321/s0004-06142010000900012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
40
|
Varela R, García HA, Cortés V. Testicular hemangiopericytoma, solitary fibrous tumor: a very rare case. ARCH ESP UROL 2010; 63:816-819. [PMID: 21113086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
OBJECTIVE To describe the case of a patient with paratesticular hemangiopericytoma and to perform a bibliographic review. METHODS We describe the case of a patient with paratesticular hemangiopericytoma. We conducted an exhaustive literature review in different databases to support the case discussion. RESULTS We present the case of a 64 year old male with a progressively growing mass in the right scrotum that underwent complete resection of the mass. The result of the pathology report was hemangiopericytoma / solitary fibrous tumor and we present the treatment. CONCLUSIONS We present a rare case of paratesticular hemangiopericytoma. Most of these have a benign outcome, but one must take into account the criteria of malignancy to make decisions regarding their management.
Collapse
Affiliation(s)
- Rodolfo Varela
- Urology Department, Instituto Nacional de Cancerologia, Bogota, Colombia.
| | | | | |
Collapse
|
41
|
Calvo-Villas JM, Martín A, Conde E, Pascual A, Heras I, Varela R, de la Rubia J, Ramirez MJ, Díez-Martín JL, Panizo C, Rodríguez-Salazar MJ, Pascual MJ, Donato EM, González-Barca E, Caballero MD. Effect of addition of rituximab to salvage chemotherapy on outcome of patients with diffuse large B-cell lymphoma relapsing after an autologous stem-cell transplantation. Ann Oncol 2010; 21:1891-1897. [PMID: 20231299 DOI: 10.1093/annonc/mdq035] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND We have investigated if rituximab-based salvage regimens improve response rates and survival of patients with diffuse large B-cell lymphoma (DLBCL) relapsing after an autologous stem-cell transplantation (ASCT). PATIENTS AND METHODS We have retrospectively analyzed 82 patients with DLBCL who received salvage therapy for relapse or progression after ASCT. Patients were divided into two groups, according to whether rituximab-based salvage regimens were given (n = 42, 'R-' group) or not (n = 40, 'R+' group) after ASCT. RESULTS Patients in the R+ group had better complete remission (CR) (55% versus 21.4%, P = 0.006) and overall response (OR) (75% versus 40.4%, P = 0.001) rates, and better 3-year event-free survival (EFS) (37% versus 9%, P = 0.002) and overall survival (OS) (50% versus 20%, P = 0.005) than patients in the R- group. Patients retreated with rituximab had better CR (42.9% versus 21.4%, P = 0.032) and OR (66.7% versus 40.4%, P = 0.019) rates, and better OS (36.2% versus 20% at 3 years, P = 0.05) and EFS (36.2% versus 9% at 3 years, P = 0.05) than patients who received chemotherapy alone at relapse after ASCT. CONCLUSIONS The addition of rituximab to salvage chemotherapy improves response rates and EFS in patients with relapsed DLBCL after ASCT. These patients may benefit from rituximab retreatment, although larger prospective studies are needed to confirm these results.
Collapse
Affiliation(s)
- J M Calvo-Villas
- Department of Hematology, Hospital Doctor José Molina Orosa, Arrecife de Lanzarote.
| | - A Martín
- Department of Hematology, Complejo Asistencial de Zamora, Zamora
| | - E Conde
- Department of Hematology, Hospital Marqués de Valdecilla, Santander
| | - A Pascual
- Department of Hematology, Hospital Clinico Universitario San Carlos, Madrid
| | - I Heras
- Department of Hematology, Hospital Morales Meseguer, Murcia
| | - R Varela
- Department of Hematology, Hospital Juan Canalejo, La Coruña
| | | | - M J Ramirez
- Department of Hematology, Hospital General de Jerez, Jerez de la Frontera
| | | | - C Panizo
- Department of Hematology, Clínica Universitaria de Navarra, Pamplona
| | | | - M J Pascual
- Department of Hematology, Hospital Carlos Haya, Malaga
| | - E M Donato
- Department of Hematology, Hospital General de Castellón, Castellón
| | - E González-Barca
- Department of Hematology, Institut Catalá d'Oncología-Hospital Duran i Reynals, L'Hospitalet de Llobregat
| | - M D Caballero
- Department of Hematology, Hospital Clínico Universitario, Salamanca, Spain
| | | |
Collapse
|
42
|
|
43
|
Rocco B, Varela R, Verweij F. Re: Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol 2005; 173:1433. [PMID: 15758826] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
|
44
|
Matei DV, Rocco B, Varela R, Verweij F, Scardino E, Renne G, De Cobelli O. Synchronous collecting duct carcinoma and papillary renal cell carcinoma: a case report and review of the literature. Anticancer Res 2005; 25:579-86. [PMID: 15816631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
The coexistence of multiple and synchronous primary neoplasms in the same organ (including kidney) has only rarely been described in the literature. We herein present a case of collecting duct carcinoma (CDC) combined with papillary renal carcinoma (RCC) having a 57-month disease-free survival CDC is a rather rare and aggressive neoplasm of the kidney. Sharing probably the same embryological origin, synchronous or metachronous association with in situ orpapillary transitional cell carcinoma (TCC) may be found; association with RCC has been only once reported in the literature. The high incidence of c-erbB-2 oncogene amplification in CDC further characterizes this tumor as a separate entity from renal cell carcinoma, and shows some genetic characteristics in common with TCC. The histological diagnosis of Bellini CDC can be confirmed by the positive immunohistochemical staining with a collecting duct marker and distal tubule marker and negative staining with a proximal tubule marker.
Collapse
|
45
|
Rocco B, Ferrari M, Scardino E, Matei DV, Verweij F, Varela R, De Cobelli O. Gn-RH antagonist possible response, after Gn-RH agonist failure in a man with metastatic prostate cancer. Anticancer Res 2005; 25:577-8. [PMID: 15816630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical castration is often considered the treatment of choice as it is psychologically better tolerated. We report our experience of one patient undergoing treatment with Gn-RH agonist who developed an early resistance to the administered drug, with serum testosterone levels within the range of normality.
Collapse
Affiliation(s)
- B Rocco
- European Institute of Oncology, Milan, Italy.
| | | | | | | | | | | | | |
Collapse
|
46
|
Rodriguez J, Caballero MD, Gutierrez A, Solano C, Arranz R, Lahuerta JJ, Sierra J, Gandarillas M, Perez-Simon JA, Zuazu J, Lopez-Guillermo A, Sureda A, Carreras E, Garcia-Laraña J, Marin J, Garcia JC, Fernandez De Sevilla A, Rifon J, Varela R, Jarque I, Albo C, Leon A, SanMiguel J, Conde E. Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience. Ann Oncol 2004; 15:1504-9. [PMID: 15367411 DOI: 10.1093/annonc/mdh391] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Here we evaluate the results of high-dose chemotherapy and autologous stem-cell transplantation (HDC/ASCT) in 114 patients included in the GEL/TAMO registry between January 1990 and December 1999 with diffuse large B-cell lymphoma who failed to achieve complete remission (CR) with front-line conventional chemotherapy. PATIENTS AND METHODS Sixty-eight per cent had a partial response (PR) and 32% failed to respond to front-line therapy. At transplant, 35% were chemoresistant and 29% had two to three adjusted International Prognostic Index (a-IPI) risk factors. RESULTS After HDC/ASCT, 57 (54%) of 105 patients evaluable for response achieved a CR, 16 (15%) a PR and 32 (30%) failed. Nine patients were not assessed for response because of early death due to toxicity. With a median follow-up of 29 months for alive patients, the survival at 5 years is 43%, with a disease-free survival for complete responders of 63%. The lethal toxicity was 8%. Multivariate analysis revealed a-IPI and chemoresistance to be predicting factors. CONCLUSIONS Our results show that one-third of patients who do not obtain a CR to front-line chemotherapy may be cured of their disease with HDC/ASCT. However, most chemoresistant patients pretransplant failed this therapy. For this population, as well as for those who presented with adverse factors of the a-IPI, pretransplant novel therapeutic modalities need to be tested.
Collapse
Affiliation(s)
- J Rodriguez
- Hospital Son Dureta, Palma de Mallorca, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Scardino E, Villa G, Bonomo G, Matei DV, Verweij F, Rocco B, Varela R, de Cobelli O. Magnetic resonance imaging combined with artificial erection for local staging of penile cancer. Urology 2004; 63:1158-62. [PMID: 15183971 DOI: 10.1016/j.urology.2004.01.008] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2003] [Accepted: 01/07/2004] [Indexed: 12/01/2022]
Abstract
OBJECTIVES To assess magnetic resonance imaging (MRI) combined with artificial erection for local staging of penile cancer. METHODS We compared local clinical, MRI plus artificial erection, and pathologic staging in 9 cases of penile cancer. Erection was obtained by injecting 10 microg prostaglandin E1 into the corpora cavernosa. T1-weighted and T2-weighted MRI with and without contrast was obtained using a phased array coil. Local treatment was based on tumor location and extent, as defined by the clinical and MRI findings. RESULTS The histologic diagnosis was squamous cell carcinoma in 8 patients and sarcoma in 1. The MRI and pathologic staging coincided in 8 of 9 patients. MRI, clinical, and pathologic staging coincided in 5 patients: 4 had Stage T2 and 1 had Stage T1 disease. In 2 patients, the MRI and pathologic stage was T2, but the clinical stage differed. Another patient had Stage T2 clinically but T3 by MRI and pathologic staging. In the last patient, none of the stages coincided (clinical Stage T1, MRI Stage T0, and pathologic Stage Tis). The only complication during the procedure was that 1 patient developed priapism after prostaglandin injection, which was relieved by evacuation of the corpora cavernosa. CONCLUSIONS To our knowledge, this is the first study to use artificial erection with MRI to stage local penile cancer. The method appears promising for local staging of penile cancer, but additional studies are necessary to confirm its utility.
Collapse
Affiliation(s)
- E Scardino
- Division of Urology, European Institute of Oncology, Milan, Italy
| | | | | | | | | | | | | | | |
Collapse
|
48
|
Cordonnier C, Martino R, Trabasso P, Held TK, Akan H, Ward MS, Fabian K, Ullmann AJ, Wulffraat N, Ljungman P, Alessandrino EP, Pretnar J, Gmür J, Varela R, Vitek A, Sica S, Rovira M. Mycobacterial Infection: A Difficult and Late Diagnosis in Stem Cell Transplant Recipients. Clin Infect Dis 2004; 38:1229-36. [PMID: 15127333 DOI: 10.1086/383307] [Citation(s) in RCA: 64] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2001] [Accepted: 12/15/2003] [Indexed: 12/17/2022] Open
Abstract
The Infectious Diseases Working Party of the European Blood and Marrow Transplant Group conducted a survey to obtain information about the frequency, presentation, and treatment of mycobacterial infection (MBI) in stem cell transplant (SCT) recipients. Among 29 centers, MBI was diagnosed in 0.79% of 1513 allogeneic and 0.23% of 3012 autologous SCT recipients during 1994-1998 a median of 160 days after transplantation. The mean interval between first symptoms and diagnosis was 29 days and was still longer for patients with atypical MBI or recipients of corticosteroid therapy. The prevalence of MBI was highest among those who received matched unrelated or mismatched STCs from related donors. Of 31 patients, 20 had tuberculosis, 8 had atypical MBI, and 3 had diagnoses based on histological findings only. Five patients (16%) died, all of whom had received an allogeneic SCT. Because of the increased numbers of unmatched donors and transplantation programs in countries with a high prevalence of tuberculosis, constant vigilance is required to early detect MBI in SCT recipients.
Collapse
Affiliation(s)
- C Cordonnier
- Department of Hematology, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Rodríguez J, Caballero MD, Gutiérrez A, Marín J, Lahuerta JJ, Sureda A, Carreras E, León A, Arranz R, Fernández de Sevilla A, Zuazu J, García-Laraña J, Rifon J, Varela R, Gandarillas M, SanMiguel J, Conde E. High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience. Ann Oncol 2004; 14:1768-75. [PMID: 14630683 DOI: 10.1093/annonc/mdg459] [Citation(s) in RCA: 101] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND T-cell immunophenotype constitutes an unfavorable prognostic factor in aggressive non-Hodgkin's lymphomas. High-dose chemotherapy with autologous stem-cell rescue (HDC/ASCT) is the best salvage therapy for patients with aggressive B-cell lymphomas. However, results with this therapy in peripheral T-cell lymphoma (PTCL) are not well defined. PATIENTS AND METHODS From January 1990 to December 1999, 115 patients with PTCL underwent HDC/ASCT inside the Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL-TAMO) registry. At diagnosis the median age was 41 years and 60% of patients presented with two or three risk factors from the adjusted International Prognostic Index (a-IPI). Thirty-two per cent of patients were transplanted in first complete response (CR), 62% in chemosensitive disease and 5% in refractory disease. RESULTS Eighty-six per cent of the patients attained a CR and 5% a partial response (PR). With a median follow-up of 37 months (range 1-133), overall survival (OS), time-to-treatment failure (TTF) and disease-free survival (DFS) at 5 years was 56%, 51% and 60%, respectively; for the 37 patients transplanted in first CR, OS and DFS at 5 years were 80% and 79%, respectively. Lactase dehydrogenase (LDH), a-IPI and disease status pre-transplant were associated with outcome. CONCLUSIONS More than half of patients with chemosensitive disease who were transplanted are expected to be alive at 5 years. We confirm the utility of the pre-transplant IPI system in predicting outcome. Salvage treatment results with HDC/ASCT in PTCL are similar to those found in corresponding aggressive B-cell lymphomas.
Collapse
Affiliation(s)
- J Rodríguez
- Hospital Son Dureta, Palma de Mallorca, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Caballero MD, Pérez-Simón JA, Iriondo A, Lahuerta JJ, Sierra J, Marín J, Gandarillas M, Arranz R, Zuazu J, Rubio V, Fernández de Sevilla A, Carreras E, García-Conde J, García-Laraña J, Grande C, Sureda A, Vidal MJ, Rifón J, Pérez-Equiza C, Varela R, Moraleda JM, García Ruíz JC, Albó C, Cabrera R, San Miguel JF, Conde E. High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Ann Oncol 2003; 14:140-51. [PMID: 12488306 DOI: 10.1093/annonc/mdg008] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND The purpose of this study was to analyse the results and prognostic factors influencing overall survival (OS) and disease-free survival (DFS) in 452 patients diagnosed with diffuse large cell lymphomas (DLCL) treated with high-dose therapy (HDT) included in the Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL-TAMO) Spanish registry. PATIENTS AND METHODS At transplantation, median age was 42 years (range 15-73), 146 patients (32%) were transplanted in first complete remission (1st CR), 19% in second CR (2nd CR) and 47% had active disease: sensitive disease in 157 (35%) patients [95 were in first partial remission (1st PR) and 62 in second PR (2nd PR)] and refractory disease in 55 (12%) patients. Age-adjusted International Prognostic Index (IPI) was 2 or 3 in 51 patients (12%). Conditioning regimen consisted of BEAM (carmustine, etoposide, cytarabine and melphalan) in 39% of patients, BEAC (carmustine, etoposide, cytarabine and cyclophosphamide) in 33%, CBV (carmustine, etoposide and cyclophosphamide) in 10% and cyclophosphamide plus total body irradiation (TBI) in 12%. RESULTS Estimated overall survival (OS) and disease-free survival (DFS) at 5 years were 53% and 43%, respectively. The transplant-related mortality was 11% (53 cases). By multivariate analysis three variables significantly influenced OS and DFS: number of protocols to reach 1st CR, disease status at transplant and TBI in the conditioning regimen. Age-adjusted IPI at transplantation also influenced OS. CONCLUSIONS Prolonged OS and DFS can be achieved in patients with DLCL after HDT and our results suggest that the best line of chemotherapy should be used up-front in patients considered as candidates for HDT in order to obtain an early CR. Resistant patients are not good candidates for HDT and they should be offered newer strategies. Finally, polichemotherapy conditioning regimens offer better results compared with TBI.
Collapse
|